|
covid-19 |
127 |
|
humans |
112 |
|
sars-cov-2 |
96 |
|
female |
82 |
|
male |
81 |
|
adult |
80 |
|
coronavirus |
67 |
|
middle aged |
64 |
|
animals |
55 |
|
hong kong - epidemiology |
48 |
|
child |
44 |
|
adolescent |
41 |
|
aged |
41 |
|
child, preschool |
40 |
|
infant |
40 |
|
influenza |
40 |
|
hong kong |
38 |
|
phylogeny |
38 |
|
molecular sequence data |
36 |
|
base sequence |
35 |
|
cell line |
35 |
|
antiviral |
33 |
|
disease outbreaks |
33 |
|
polymerase chain reaction |
32 |
|
sars-cov |
32 |
|
mice |
31 |
|
reverse transcriptase polymerase chain reaction |
30 |
|
time factors |
30 |
|
retrospective studies |
29 |
|
viral load |
29 |
|
genotype |
28 |
|
incidence |
28 |
|
risk factors |
28 |
|
sequence analysis, dna |
28 |
|
transmission |
28 |
|
h5n1 |
27 |
|
interferon |
27 |
|
pathogenesis |
27 |
|
rna, viral - genetics |
27 |
|
treatment |
27 |
|
sensitivity and specificity |
26 |
|
china |
25 |
|
china - epidemiology |
25 |
|
flavivirus |
25 |
|
lipidomics |
25 |
|
epidemiology |
24 |
|
mutation |
24 |
|
sars |
24 |
|
zika |
24 |
|
genome, viral |
23 |
|
human |
23 |
|
medical sciences |
23 |
|
prospective studies |
23 |
|
aged, 80 and over |
22 |
|
antibodies, viral - blood |
22 |
|
bone marrow transplantation - adverse effects |
22 |
|
mouse |
22 |
|
treatment outcome |
22 |
|
viral replication |
22 |
|
amino acid sequence |
21 |
|
bone marrow transplantation |
21 |
|
cattle |
21 |
|
diagnosis |
21 |
|
enterovirus |
21 |
|
hemagglutinin |
21 |
|
microbial sensitivity tests |
21 |
|
survival rate |
21 |
|
temperature |
21 |
|
animal |
20 |
|
bat |
20 |
|
biomarkers |
20 |
|
children |
20 |
|
chiroptera - virology |
20 |
|
h7n9 |
20 |
|
immunocompromised host |
20 |
|
influenza virus |
20 |
|
molecular epidemiology |
20 |
|
pandemic |
20 |
|
ace2 |
19 |
|
burkholderia pseudomallei |
19 |
|
feces - virology |
19 |
|
severe acute respiratory syndrome |
19 |
|
susceptibility |
19 |
|
vaccine |
19 |
|
antibody |
18 |
|
blotting, western |
18 |
|
cohort studies |
18 |
|
influenza, human - epidemiology - virology |
18 |
|
melioidosis |
18 |
|
mers-cov |
18 |
|
metabolomics |
18 |
|
mucosal immunity |
18 |
|
neutralizing antibody |
18 |
|
novel |
18 |
|
prognosis |
18 |
|
receptor binding domain |
18 |
|
age factors |
17 |
|
anti-bacterial agents - pharmacology |
17 |
|
enzyme-linked immunosorbent assay |
17 |
|
fatal outcome |
17 |
|
follow-up studies |
17 |
|
influenza, human - virology |
17 |
|
inhibitor |
17 |
|
mutation - genetics |
17 |
|
nasopharynx - virology |
17 |
|
outbreak |
17 |
|
seasons |
17 |
|
birds - virology |
16 |
|
convalescence |
16 |
|
cytokine |
16 |
|
dna primers |
16 |
|
dogs |
16 |
|
evolution, molecular |
16 |
|
fatty acid |
16 |
|
genetic variation |
16 |
|
hamster |
16 |
|
influenza a virus |
16 |
|
influenza a virus, h1n1 subtype - immunology |
16 |
|
polymerase chain reaction - methods |
16 |
|
sars virus - immunology |
16 |
|
serology |
16 |
|
t-lymphocytes, cytotoxic - immunology |
16 |
|
uplc-esi-q-tof-ms |
16 |
|
virus replication |
16 |
|
young adult |
16 |
|
amino acid substitution |
15 |
|
animal experiment |
15 |
|
anosmia |
15 |
|
disease outbreaks - statistics & numerical data |
15 |
|
genome |
15 |
|
immune response |
15 |
|
influenza, human - diagnosis - virology |
15 |
|
live attenuated vaccine |
15 |
|
neutralization tests |
15 |
|
olfactory dysfunction |
15 |
|
pcr |
15 |
|
penicillium marneffei |
15 |
|
rat |
15 |
|
remdesivir |
15 |
|
administration, oral |
14 |
|
bacterial typing techniques |
14 |
|
bronchiectasis |
14 |
|
cell line, tumor |
14 |
|
chemicals and cas registry numbers |
14 |
|
coronavirus - classification - genetics - isolation & purification |
14 |
|
diagnosis, differential |
14 |
|
diagnostics |
14 |
|
drug therapy, combination |
14 |
|
h1n1 |
14 |
|
immune activation |
14 |
|
infection |
14 |
|
influenza a |
14 |
|
influenza, human - immunology - pathology - virology |
14 |
|
intestine |
14 |
|
microscopy, electron |
14 |
|
omicron |
14 |
|
pathogenicity |
14 |
|
plasma |
14 |
|
polymorphism, genetic |
14 |
|
protease |
14 |
|
replication |
14 |
|
rhizopus microsporus |
14 |
|
species specificity |
14 |
|
swine - virology |
14 |
|
virus evolution |
14 |
|
virus replication - physiology |
14 |
|
adaptation |
13 |
|
age |
13 |
|
antibiotic prophylaxis |
13 |
|
bacterial proteins - genetics |
13 |
|
betacoronavirus |
13 |
|
bunyavirales |
13 |
|
chinese |
13 |
|
clarithromycin |
13 |
|
cluster analysis |
13 |
|
cytokine and chemokine response |
13 |
|
d222g |
13 |
|
disease progression |
13 |
|
disease reservoirs - virology |
13 |
|
dna, viral - genetics |
13 |
|
electrophoresis, gel, pulsed-field |
13 |
|
inactivated vaccine |
13 |
|
nucleoprotein |
13 |
|
reproducibility of results |
13 |
|
rnai |
13 |
|
sace2 |
13 |
|
sars virus - genetics - isolation & purification |
13 |
|
sars-cov-2 variants |
13 |
|
species index: fungi |
13 |
|
spike protein |
13 |
|
transfection |
13 |
|
acute hepatitis |
12 |
|
adolescents |
12 |
|
animal tissue |
12 |
|
antiviral agents - pharmacology |
12 |
|
avian |
12 |
|
biomarker |
12 |
|
case report |
12 |
|
chronic obstructive lung disease |
12 |
|
controlled study |
12 |
|
coronavirus - genetics - isolation & purification |
12 |
|
coronavirus disease 2019 |
12 |
|
disease outbreaks - prevention & control |
12 |
|
dna, bacterial - genetics |
12 |
|
epidemics |
12 |
|
false positive |
12 |
|
flow cytometry |
12 |
|
infectivity |
12 |
|
influenza a virus, h1n1 subtype - genetics |
12 |
|
influenza, human - epidemiology - immunology - virology |
12 |
|
kawasaki disease |
12 |
|
lopinavir |
12 |
|
mice, inbred balb c |
12 |
|
microbiology |
12 |
|
mycobacterium tuberculosis |
12 |
|
neutralizing antibodies |
12 |
|
organ size |
12 |
|
pneumonia |
12 |
|
real-time pcr |
12 |
|
respiratory tract infections |
12 |
|
rna, ribosomal, 16s - genetics |
12 |
|
sars virus - isolation & purification |
12 |
|
sars-cov-2 rbd igg |
12 |
|
serotyping |
12 |
|
severe acute respiratory syndrome - diagnosis - virology |
12 |
|
severe acute respiratory syndrome - drug therapy |
12 |
|
severity of illness index |
12 |
|
sftsv |
12 |
|
staphylococcus aureus |
12 |
|
swine diseases - virology |
12 |
|
t cell response |
12 |
|
transcription, genetic |
12 |
|
urine - virology |
12 |
|
virulence |
12 |
|
2′-o-methyltransferase |
11 |
|
amino acid substitution - genetics |
11 |
|
animal cell |
11 |
|
animal model |
11 |
|
anthranilic acid |
11 |
|
antibodies, viral - biosynthesis |
11 |
|
antibody titer |
11 |
|
antiviral agents - chemical synthesis - chemistry - pharmacology |
11 |
|
bacteriological techniques - methods |
11 |
|
broad spectrum |
11 |
|
carboxypeptidases - antagonists & inhibitors - metabolism |
11 |
|
chemokine |
11 |
|
coinfection |
11 |
|
dna, bacterial - chemistry - genetics |
11 |
|
elderly |
11 |
|
endoplasmic reticulum |
11 |
|
entry |
11 |
|
feces analysis |
11 |
|
genes, rrna |
11 |
|
graft rejection |
11 |
|
graft survival |
11 |
|
hcov-229e |
11 |
|
human immunodeficiency virus |
11 |
|
influenza in birds - epidemiology - transmission - virology |
11 |
|
intradermal |
11 |
|
macrophages |
11 |
|
murine |
11 |
|
n501y |
11 |
|
nsp16 |
11 |
|
nucleocapsid proteins - genetics - immunology |
11 |
|
open reading frames - genetics |
11 |
|
recombination, genetic |
11 |
|
reverse transcriptase polymerase chain reaction - methods |
11 |
|
saliva |
11 |
|
sars coronavirus |
11 |
|
sars virus - drug effects - growth & development - metabolism - physiology |
11 |
|
sequence homology, amino acid |
11 |
|
seroepidemiologic studies |
11 |
|
sterilizing immunity |
11 |
|
stool |
11 |
|
t-cell response |
11 |
|
vaccination |
11 |
|
viral matrix proteins - antagonists & inhibitors - metabolism |
11 |
|
virus |
11 |
|
virus cultivation |
11 |
|
adenovirus |
10 |
|
airborne infection |
10 |
|
antigen-presentation |
10 |
|
autoantibody |
10 |
|
avian influenza |
10 |
|
bacteremia |
10 |
|
blood donors |
10 |
|
canada - epidemiology |
10 |
|
carrier state - microbiology |
10 |
|
cell tropism |
10 |
|
chick embryo |
10 |
|
convalescent |
10 |
|
coronavirus - classification - genetics |
10 |
|
coronavirus - immunology - pathogenicity - physiology |
10 |
|
coronavirus infection |
10 |
|
coronavirus infections - immunology - virology |
10 |
|
covid19 |
10 |
|
cross reactions |
10 |
|
cytokines |
10 |
|
cytokines - biosynthesis - immunology |
10 |
|
cytokines - blood |
10 |
|
cytomegalovirus |
10 |
|
d225g |
10 |
|
damplicon |
10 |
|
diarrhea - epidemiology - microbiology |
10 |
|
diarrhea - microbiology |
10 |
|
disease reservoirs |
10 |
|
ducks - virology |
10 |
|
fluorescent antibody technique, indirect |
10 |
|
food microbiology |
10 |
|
genes, bacterial |
10 |
|
genome, bacterial |
10 |
|
hemagglutinin glycoproteins, influenza virus - genetics - metabolism |
10 |
|
human neutralizing antibody |
10 |
|
immunoglobulin g - blood |
10 |
|
immunosuppressive agents - therapeutic use |
10 |
|
influenza a virus, h1n1 subtype - genetics - pathogenicity |
10 |
|
influenza a virus, h1n1 subtype - isolation and purification |
10 |
|
influenza a virus, h1n1 subtype - physiology |
10 |
|
influenza a virus, h5n1 subtype - physiology |
10 |
|
influenza h1n1 |
10 |
|
influenza in birds - virology |
10 |
|
influenza vaccine |
10 |
|
influenza, human - epidemiology - transmission - virology |
10 |
|
injections, intramuscular |
10 |
|
linker-immunodominant site |
10 |
|
liver function tests |
10 |
|
lung injury |
10 |
|
nasal turbinate |
10 |
|
open reading frames |
10 |
|
peptide |
10 |
|
phage display |
10 |
|
picornaviridae - chemistry - classification - genetics - isolation and purification |
10 |
|
pneumonia, viral - immunology - virology |
10 |
|
respiratory system - virology |
10 |
|
sars virus - genetics |
10 |
|
sars virus - isolation and purification |
10 |
|
sequence homology, nucleic acid |
10 |
|
seroprevalence |
10 |
|
severe acute respiratory syndrome - virology |
10 |
|
sialic acid |
10 |
|
smell impairment |
10 |
|
specific |
10 |
|
swine-origin |
10 |
|
t-lymphocytes - immunology |
10 |
|
upper respiratory tract |
10 |
|
virology |
10 |
|
virus shedding |
10 |
|
5' untranslated regions |
9 |
|
acute disease |
9 |
|
adenosine synthase a |
9 |
|
aged mice |
9 |
|
airway organoid |
9 |
|
alleles |
9 |
|
anti-bacterial agents - therapeutic use |
9 |
|
antibodies, neutralizing - blood |
9 |
|
antibody-dependent cell-mediated cytotoxicity |
9 |
|
antigens, viral - analysis |
9 |
|
antitubercular agents - therapeutic use |
9 |
|
antiviral agents - administration and dosage - therapeutic use |
9 |
|
apoptosis |
9 |
|
asia, southeastern |
9 |
|
ba.5.2 |
9 |
|
bacteriological techniques |
9 |
|
bagg albino mouse |
9 |
|
bioaerosols |
9 |
|
bocavirus - classification - genetics - isolation and purification |
9 |
|
celecoxib |
9 |
|
cell surface |
9 |
|
clinical outcome |
9 |
|
comorbidity |
9 |
|
coronavac |
9 |
|
coronavirus infections - genetics |
9 |
|
covid‐19 |
9 |
|
cross infection - epidemiology - immunology |
9 |
|
cross protection |
9 |
|
cytopathogenic effect, viral |
9 |
|
dogs - virology |
9 |
|
drug resistance, bacterial |
9 |
|
drug resistance, bacterial - genetics |
9 |
|
emerging |
9 |
|
ex vivo |
9 |
|
fc-rbd |
9 |
|
gram-negative bacterial infections - diagnosis - microbiology |
9 |
|
h1n1 influenza virus |
9 |
|
hku1 |
9 |
|
hospitals, university |
9 |
|
human adenovirus |
9 |
|
human primary nasal epithelial cells |
9 |
|
illumina sequencing |
9 |
|
immune imprinting |
9 |
|
immune protection |
9 |
|
immunization |
9 |
|
immunoglobulin g - analysis - immunology |
9 |
|
immunohistochemistry |
9 |
|
infant, newborn |
9 |
|
influenza a virus, h1n1 subtype - genetics - isolation and purification - physiology |
9 |
|
influenza vaccines - administration and dosage |
9 |
|
internalization |
9 |
|
laribacter hongkongensis |
9 |
|
liver diseases - epidemiology |
9 |
|
liver transplantation - statistics & numerical data |
9 |
|
lung - radiography |
9 |
|
lung damage |
9 |
|
membrane glycoproteins - analysis |
9 |
|
membrane glycoproteins - chemistry - genetics |
9 |
|
membrane glycoproteins - immunology |
9 |
|
mers |
9 |
|
mesalazine |
9 |
|
middle east respiratory syndrome coronavirus |
9 |
|
model |
9 |
|
mrsa |
9 |
|
myocardial infarction - mortality - prevention and control |
9 |
|
novel species |
9 |
|
nucleocapsid proteins - genetics |
9 |
|
nucleolin |
9 |
|
omicron variant |
9 |
|
operating rooms |
9 |
|
orchitis |
9 |
|
orthomyxoviridae infections - immunology - mortality - physiopathology - virology |
9 |
|
oseltamivir |
9 |
|
parvoviridae infections - veterinary - virology |
9 |
|
phenotype |
9 |
|
phosphatidic acid phosphatases |
9 |
|
pneumococcal vaccines - administration and dosage |
9 |
|
pneumonia, viral - epidemiology - immunology - virology |
9 |
|
pneumonia, viral - virology |
9 |
|
point-of-care testing |
9 |
|
polymorphism, single nucleotide |
9 |
|
post-ba.2/5 subvariants |
9 |
|
proximal differentiation |
9 |
|
recombinant proteins - analysis - immunology |
9 |
|
respiratory |
9 |
|
respiratory tract infection |
9 |
|
resting-state fmri |
9 |
|
rhinovirus |
9 |
|
ribosomes - genetics - metabolism |
9 |
|
rna interference |
9 |
|
sars-cov-2 variants of concern |
9 |
|
sars‐cov‐2 |
9 |
|
sequence alignment |
9 |
|
seroepidemiology |
9 |
|
severe acute respiratory syndrome - epidemiology - immunology - virology |
9 |
|
severe acute respiratory syndrome - epidemiology - transmission - virology |
9 |
|
severe acute respiratory syndrome - immunology - virology |
9 |
|
steroid |
9 |
|
stroke - mortality - prevention and control |
9 |
|
swine |
9 |
|
talaromyces marneffei |
9 |
|
testis |
9 |
|
tissue donors |
9 |
|
transplantation, homologous - adverse effects |
9 |
|
vaccination - methods |
9 |
|
vaccines, dna - administration & dosage - immunology |
9 |
|
viral envelope proteins - analysis |
9 |
|
viral envelope proteins - chemistry - genetics |
9 |
|
viral envelope proteins - genetics - immunology |
9 |
|
viral proteins - genetics |
9 |
|
vitamin a |
9 |
|
vopba |
9 |
|
weanling mice |
9 |
|
xbb.1 |
9 |
|
zanamivir |
9 |
|
zika virus |
9 |
|
zoonosis |
9 |
|
2009 h1n1 influenza |
8 |
|
25-hydroxycholesterol |
8 |
|
3clpro inhibitor |
8 |
|
a(h1n1)pdm09 |
8 |
|
a(h3n2) |
8 |
|
acute infection |
8 |
|
adjuvant |
8 |
|
aerosolised |
8 |
|
allosteric-site inhibitor |
8 |
|
am580 |
8 |
|
animal models |
8 |
|
antibody blood level |
8 |
|
antibody detection |
8 |
|
antibody formation |
8 |
|
antibody response |
8 |
|
antifungal agents - therapeutic use |
8 |
|
antiviral agents - therapeutic use |
8 |
|
aspergillus |
8 |
|
aspergillus fumigatus |
8 |
|
asymptomatic |
8 |
|
asymptomatic infection |
8 |
|
autopsy |
8 |
|
avian influenza virus |
8 |
|
b cell |
8 |
|
b-cell suppression |
8 |
|
bacteremia - microbiology |
8 |
|
balb/c mice |
8 |
|
biliary atresia - complications - surgery |
8 |
|
binding sites |
8 |
|
biology |
8 |
|
biotechnology technology: comprehensive works medical sciences chemistry |
8 |
|
bone marrow transplantation - immunology |
8 |
|
broad-spectrum antiviral treatment |
8 |
|
case study |
8 |
|
case-control studies |
8 |
|
caspase |
8 |
|
chemical genetics |
8 |
|
chi-square distribution |
8 |
|
chicken |
8 |
|
clade 2.3.4.4b |
8 |
|
cloning, molecular |
8 |
|
clostridium difficile |
8 |
|
combination therapy |
8 |
|
complications of liver transplantation |
8 |
|
conjunctiva |
8 |
|
coronavirus - immunology |
8 |
|
coronavirus hku1 |
8 |
|
coronavirus infections - epidemiology - physiopathology - virology |
8 |
|
cross-reactive |
8 |
|
cyclosporine - therapeutic use |
8 |
|
cytokines - genetics - metabolism |
8 |
|
databases, nucleic acid - statistics & numerical data |
8 |
|
delns1-ncov-rbd laiv |
8 |
|
dendritic cell |
8 |
|
detection |
8 |
|
diagnostic |
8 |
|
dialysis |
8 |
|
dipeptidyl peptidase 4 |
8 |
|
dna, viral - chemistry - genetics |
8 |
|
dog diseases - virology |
8 |
|
dromedary camel |
8 |
|
drug synergism |
8 |
|
early |
8 |
|
early diagnosis |
8 |
|
emc |
8 |
|
fishes - microbiology |
8 |
|
functional brain network |
8 |
|
ganglioside gm1 antibody |
8 |
|
gastroenteritis |
8 |
|
gastroenteritis - microbiology |
8 |
|
gastrointestinal diseases - microbiology |
8 |
|
gene deletion |
8 |
|
gene expression regulation, bacterial |
8 |
|
gene silencing |
8 |
|
genetics |
8 |
|
genome, fungal |
8 |
|
glycolipids |
8 |
|
gram-positive bacterial infections - microbiology |
8 |
|
hcov-emc |
8 |
|
hemagglutination inhibition tests |
8 |
|
hepatitis b vaccination |
8 |
|
high throughput screening |
8 |
|
high-risk |
8 |
|
hospitalized |
8 |
|
human rhinovirus |
8 |
|
hypsugo bat |
8 |
|
il-8 |
8 |
|
imiquimod |
8 |
|
immunization schedule |
8 |
|
immunization, secondary |
8 |
|
immunocompetence |
8 |
|
immunotherapy - methods |
8 |
|
infection control |
8 |
|
influenza a virus, h1n1 subtype - genetics - immunology - isolation and purification |
8 |
|
influenza a virus, h1n1 subtype - genetics - isolation & purification - physiology |
8 |
|
influenza a virus, h1n1 subtype - immunology - pathogenicity |
8 |
|
influenza a virus, h1n1 subtype - isolation & purification - pathogenicity |
8 |
|
influenza a virus, h5n1 subtype - immunology - pathogenicity |
8 |
|
influenza a virus, h5n1 subtype - isolation & purification - pathogenicity |
8 |
|
influenza vaccines - immunology |
8 |
|
influenza, human - epidemiology - pathology - virology |
8 |
|
influenza, human - epidemiology - prevention & control - transmission - virology |
8 |
|
influenza, human - immunology |
8 |
|
integrative-omics |
8 |
|
interferon beta-1b |
8 |
|
interferon lambda 1 |
8 |
|
interventions |
8 |
|
intranasal |
8 |
|
intraoperative complications - epidemiology |
8 |
|
leukocytes - virology |
8 |
|
lipid |
8 |
|
liver diseases - etiology - surgery |
8 |
|
liver transplantation - adverse effects - statistics & numerical data |
8 |
|
liver transplantation - contraindications - methods - mortality - statistics & numerical data |
8 |
|
liver transplantation - methods |
8 |
|
living donor liver transplant |
8 |
|
living-related liver transplantation |
8 |
|
long covid |
8 |
|
mammary gland |
8 |
|
marmosets |
8 |
|
mask |
8 |
|
membrane glycoproteins - genetics |
8 |
|
membrane glycoproteins - metabolism |
8 |
|
metabolomic |
8 |
|
metalloimmunity |
8 |
|
metalloproteomics |
8 |
|
methicillin resistance |
8 |
|
meticillin-resistant staphylococcus aureus |
8 |
|
mice, inbred c57bl |
8 |
|
microbial sensitivity tests - methods |
8 |
|
mitochondrial dysfunction |
8 |
|
nanopore sequencing |
8 |
|
naproxen |
8 |
|
neutralization |
8 |
|
ns5 |
8 |
|
nsp1 |
8 |
|
nucleic acid amplification techniques - methods |
8 |
|
nucleic acid conformation |
8 |
|
nucleocapsid proteins - immunology |
8 |
|
obesity |
8 |
|
oc43 |
8 |
|
older patients |
8 |
|
olfactory training |
8 |
|
organic acid |
8 |
|
pediatric liver transplant |
8 |
|
penicillium - genetics |
8 |
|
phase-1 |
8 |
|
phospholipids |
8 |
|
phylogenetic tree |
8 |
|
plasmids |
8 |
|
pneumococcal vaccination |
8 |
|
point mutation |
8 |
|
portoenterostomy, hepatic |
8 |
|
postoperative complications |
8 |
|
postoperative complications - classification - epidemiology |
8 |
|
postoperative complications - epidemiology |
8 |
|
poultry |
8 |
|
promoter regions, genetic |
8 |
|
randomized controlled trial |
8 |
|
rats |
8 |
|
real-time rt-pcr |
8 |
|
receptor, interferon alpha-beta - genetics |
8 |
|
recombination |
8 |
|
reduced-size liver transplant |
8 |
|
reduced-size liver transplantation |
8 |
|
reoperation |
8 |
|
respiratory tract infections - epidemiology - physiopathology - virology |
8 |
|
respiratory tract infections - virology |
8 |
|
reverse genetics |
8 |
|
rna, viral - analysis |
8 |
|
rna, viral - analysis - genetics |
8 |
|
rt-pcr |
8 |
|
rt‐pcr |
8 |
|
sars virus |
8 |
|
screening |
8 |
|
seizures, febrile - epidemiology |
8 |
|
sequencing |
8 |
|
serial |
8 |
|
serial passage |
8 |
|
shedding |
8 |
|
singapore - epidemiology |
8 |
|
smell loss |
8 |
|
sphingolipids |
8 |
|
spike |
8 |
|
spike glycoprotein |
8 |
|
spike mutant |
8 |
|
spike s1/s2 mutant |
8 |
|
spleen |
8 |
|
staphylococcal infections - microbiology |
8 |
|
t lymphocytes |
8 |
|
tissue donors - statistics & numerical data |
8 |
|
tlr7 agonist |
8 |
|
tonsil |
8 |
|
urine |
8 |
|
vancomycin-resistant enterococci |
8 |
|
vietnam - epidemiology |
8 |
|
viral envelope proteins - metabolism |
8 |
|
viral load - physiology |
8 |
|
viral matrix proteins - genetics |
8 |
|
viral proteins - chemistry - genetics |
8 |
|
virus replication - drug effects |
8 |
|
5′-race assay |
7 |
|
a(h1n1)pdm09 influenza |
7 |
|
a(h7n9) influenza |
7 |
|
activities of daily living |
7 |
|
adaptation, physiological - genetics |
7 |
|
adiponectin |
7 |
|
adoptive transfer |
7 |
|
anastomosis, roux-en-y |
7 |
|
anastomosis, surgical - methods |
7 |
|
anti-bacterial agents - pharmacology - therapeutic use |
7 |
|
antibiotic resistance |
7 |
|
antibodies, monoclonal - immunology |
7 |
|
antibodies, viral - blood - immunology |
7 |
|
antibodies, viral - genetics - immunology - metabolism |
7 |
|
antibody specificity |
7 |
|
antiviral compounds |
7 |
|
arthritis, infectious - microbiology |
7 |
|
autoclave |
7 |
|
avian influenza a/h7n9 virus |
7 |
|
bacteraemia |
7 |
|
bacteremia - diagnosis - microbiology |
7 |
|
bile duct diseases - etiology |
7 |
|
bile ducts - blood supply - surgery |
7 |
|
biliary atresia |
7 |
|
bilirubin - blood |
7 |
|
biopsy |
7 |
|
bird diseases - virology |
7 |
|
bk virus - isolation & purification |
7 |
|
blotting, southern |
7 |
|
bocaparvovirus |
7 |
|
bocavirus - classification - genetics - isolation & purification |
7 |
|
body weight |
7 |
|
broad-spectrum |
7 |
|
broadly neutralizing antibody |
7 |
|
bromocriptine |
7 |
|
caco-2 |
7 |
|
candida |
7 |
|
cats |
7 |
|
cattle - virology |
7 |
|
cattle diseases - virology |
7 |
|
cell culture |
7 |
|
chlorogenic acid - chemistry - pharmacology |
7 |
|
clade |
7 |
|
clinic |
7 |
|
colony count, microbial |
7 |
|
common cold - genetics |
7 |
|
common cold - virology |
7 |
|
community-acquired-infections-epidemiology |
7 |
|
community-acquired-infections-mortality |
7 |
|
community-acquired-infections-physiopathology |
7 |
|
community-acquired-infections-virology |
7 |
|
coronaviridae - classification - genetics - isolation and purification |
7 |
|
coronaviridae infections - veterinary - virology |
7 |
|
coronavirus - classification - genetics - immunology - metabolism |
7 |
|
coronavirus 229e, human - genetics - physiology |
7 |
|
coronavirus infections - epidemiology - immunology |
7 |
|
coronavirus infections - virology |
7 |
|
coronavirus oc43, human - classification - genetics - isolation and purification |
7 |
|
coronavirus-genetics |
7 |
|
corticosteroid |
7 |
|
cricetinae |
7 |
|
culture media |
7 |
|
culture media - chemistry |
7 |
|
cva16 |
7 |
|
defective interfering viral genome |
7 |
|
dendritic cells |
7 |
|
dental |
7 |
|
directly observed |
7 |
|
discovery |
7 |
|
disease severity |
7 |
|
diversity |
7 |
|
dna fingerprinting |
7 |
|
dna, bacterial - analysis |
7 |
|
dna, ribosomal - analysis |
7 |
|
dna, ribosomal - chemistry - genetics |
7 |
|
down-regulation |
7 |
|
enterovirus d68 |
7 |
|
enzyme activation |
7 |
|
epidemiology, molecular |
7 |
|
escherichia coli |
7 |
|
etiology |
7 |
|
ev-a71 |
7 |
|
evaluation |
7 |
|
face masks |
7 |
|
fecal |
7 |
|
fish diseases - microbiology |
7 |
|
flavonoids - chemistry - pharmacology |
7 |
|
fluorescein-5-isothiocyanate - metabolism |
7 |
|
fluorescent dyes - metabolism |
7 |
|
fungus protein |
7 |
|
furin cleavage prra motif |
7 |
|
furin inhibitor |
7 |
|
gastroenteritis - epidemiology - microbiology |
7 |
|
gastroenteritis - epidemiology - physiopathology - virology |
7 |
|
gene |
7 |
|
genes, bacterial - genetics |
7 |
|
genetic predisposition to disease |
7 |
|
genetic vectors |
7 |
|
genetic vectors - genetics |
7 |
|
genomic sequence |
7 |
|
genomics |
7 |
|
glycoprotein |
7 |
|
glycosylation |
7 |
|
glycyrrhizic acid - chemistry - pharmacology |
7 |
|
h7n7 virus |
7 |
|
hand hygiene |
7 |
|
handwashing - methods |
7 |
|
hbv infection |
7 |
|
hela cells |
7 |
|
hemagglutinins - genetics |
7 |
|
hematopoietic stem cell transplantation - adverse effects |
7 |
|
hemolysis |
7 |
|
hepatic artery - surgery |
7 |
|
hepatic encephalopathy - surgery |
7 |
|
hepatitis - surgery |
7 |
|
hepatitis b virus |
7 |
|
hepatitis b, chronic - genetics - immunology - metabolism |
7 |
|
high infection rate |
7 |
|
histocompatibility |
7 |
|
human coronavirus hku1 |
7 |
|
icu patient |
7 |
|
ifnar1 |
7 |
|
immunity |
7 |
|
immunology |
7 |
|
immunosuppression - adverse effects |
7 |
|
infection control - methods |
7 |
|
infectious disease |
7 |
|
influenza, human - drug therapy - epidemiology - virology |
7 |
|
injections, intraperitoneal |
7 |
|
interferon antagonist |
7 |
|
interferon-alpha - pharmacology |
7 |
|
interferon-beta - pharmacology |
7 |
|
interspecies |
7 |
|
intestinal organoids |
7 |
|
ire1 |
7 |
|
kidney - cytology |
7 |
|
klebsiella infections - epidemiology - microbiology |
7 |
|
klebsiella oxytoca - classification - genetics - isolation and purification - pathogenicity |
7 |
|
length of stay |
7 |
|
leptin |
7 |
|
life cycle |
7 |
|
lightmix e-gene |
7 |
|
liver diseases - congenital - mortality - surgery |
7 |
|
liver failure - surgery |
7 |
|
liver transplantation - adverse effects - methods - mortality |
7 |
|
liver transplantation - adverse effects - methods - pathology - statistics & numerical data |
7 |
|
liver transplantation - methods - physiology |
7 |
|
liver transplantation - mortality |
7 |
|
living donors |
7 |
|
living donors - classification |
7 |
|
lung eqtl |
7 |
|
mammals - virology |
7 |
|
maturation |
7 |
|
mdms |
7 |
|
membrane glycoproteins - genetics - immunology |
7 |
|
membrane glycoproteins - genetics - immunology - metabolism |
7 |
|
mers coronavirus |
7 |
|
methicillin-resistant staphylococcus aureus |
7 |
|
methicillin-resistant staphylococcus aureus - isolation and purification |
7 |
|
microsurgery |
7 |
|
microvascular anastomosis |
7 |
|
miltefosine |
7 |
|
modcs |
7 |
|
models, molecular |
7 |
|
monoinfection |
7 |
|
ms |
7 |
|
multigene family |
7 |
|
multivariate analysis |
7 |
|
mutation, missense |
7 |
|
mycological typing techniques - methods |
7 |
|
nasopharynx/virology |
7 |
|
native conformation |
7 |
|
neisseriaceae - genetics |
7 |
|
neisseriaceae - genetics - isolation & purification |
7 |
|
neurogenesis |
7 |
|
neutralization antibody |
7 |
|
nglycosylation |
7 |
|
nlrp3 inflammasome |
7 |
|
nsp3 |
7 |
|
nucleocapsid - analysis |
7 |
|
olfactory neuron |
7 |
|
orf6 |
7 |
|
oseltamivir - administration and dosage - therapeutic use |
7 |
|
pa protein |
7 |
|
parvoviridae infections - epidemiology - physiopathology - virology |
7 |
|
parvovirinae - classification - genetics - isolation and purification |
7 |
|
parvovirus - classification - genetics - isolation and purification |
7 |
|
parvovirus - genetics - isolation and purification |
7 |
|
pediatric liver transplantation |
7 |
|
phylodynamic |
7 |
|
phylogenetic |
7 |
|
physiological processes - genetics |
7 |
|
plasma - immunology |
7 |
|
plasmids - genetics |
7 |
|
plpro |
7 |
|
polymorphism, restriction fragment length |
7 |
|
postoperative complications - prevention & control |
7 |
|
postoperative complications - prevention & control - surgery |
7 |
|
predictive value of tests |
7 |
|
pregnancy |
7 |
|
preoperative care |
7 |
|
prevalence |
7 |
|
protein structure, tertiary |
7 |
|
proteome |
7 |
|
pyrimidinones - pharmacology |
7 |
|
recombinant proteins - immunology - metabolism |
7 |
|
registries |
7 |
|
reinfection |
7 |
|
respiratory tract infections - epidemiology - virology |
7 |
|
respiratory virus |
7 |
|
respiratory viruses |
7 |
|
rhinovirus - classification - genetics |
7 |
|
ribavirin - pharmacology |
7 |
|
rimantadine - pharmacology |
7 |
|
risk assessment |
7 |
|
rna, bacterial - genetics |
7 |
|
rna, messenger - genetics - metabolism |
7 |
|
route of transmission |
7 |
|
sars cov |
7 |
|
sars virus - chemistry |
7 |
|
sars virus - classification - genetics - isolation & purification |
7 |
|
sars virus - drug effects |
7 |
|
sars virus - genetics - immunology |
7 |
|
sars virus - genetics - physiology |
7 |
|
sepsis - prevention & control |
7 |
|
severe |
7 |
|
severe acute respiratory syndrome - blood - physiopathology - urine - virology |
7 |
|
severe acute respiratory syndrome - diagnosis |
7 |
|
severe acute respiratory syndrome - genetics |
7 |
|
sheep - virology |
7 |
|
single molecule real time sequencing |
7 |
|
single-tube nested |
7 |
|
small-molecule inhibitor |
7 |
|
snp |
7 |
|
spermatogenesis |
7 |
|
stability |
7 |
|
stents |
7 |
|
sterilization |
7 |
|
subgenomic transcripts |
7 |
|
surface expression |
7 |
|
t cell responses |
7 |
|
tfh |
7 |
|
thrombosis - prevention & control |
7 |
|
tmprss2 |
7 |
|
transcription regulation |
7 |
|
travel |
7 |
|
uhplc |
7 |
|
untranslated |
7 |
|
upr |
7 |
|
vascular surgical procedures - methods |
7 |
|
viral envelope proteins - genetics - immunology - metabolism |
7 |
|
viral genome |
7 |
|
viral isolation |
7 |
|
viral plaque assay |
7 |
|
viral proteins - blood - genetics |
7 |
|
viral variants |
7 |
|
virulence factors |
7 |
|
virus maturation |
7 |
|
whole-genome sequencing |
7 |
|
zoonoses |
7 |
|
2019 novel coronavirus |
6 |
|
3' untranslated regions |
6 |
|
acquired immunodeficiency syndrome - complications - etiology |
6 |
|
acupuncture therapy - adverse effects |
6 |
|
air sampling |
6 |
|
amantadine-pharmacology |
6 |
|
amoxicillin-potassium clavulanate combination - administration & dosage |
6 |
|
amoxicillin-potassium clavulanate combination - therapeutic use |
6 |
|
anaerobic bacteria |
6 |
|
animals, domestic |
6 |
|
animals, domestic - microbiology |
6 |
|
animals, wild - virology |
6 |
|
anti-bacterial agents |
6 |
|
antibody assay |
6 |
|
antigen |
6 |
|
antigenic cartography |
6 |
|
antigenic distance |
6 |
|
antigenic field |
6 |
|
ar-12 |
6 |
|
arachidonic acid |
6 |
|
arbovirus |
6 |
|
artenimol |
6 |
|
aspergillus hongkongensis sp. nov. |
6 |
|
astrovirus |
6 |
|
autoantibodies - blood |
6 |
|
automated |
6 |
|
bacteremia - complications - microbiology |
6 |
|
bacteremia - diagnosis |
6 |
|
bacteremia - epidemiology - microbiology |
6 |
|
bacteria, aerobic - classification - genetics - isolation and purification |
6 |
|
bacterial proteins |
6 |
|
bacterial vaccines - administration & dosage - immunology |
6 |
|
bacterium |
6 |
|
base composition |
6 |
|
bat screening |
6 |
|
bile |
6 |
|
biliary |
6 |
|
biomedicine |
6 |
|
bird diseases - epidemiology - virology |
6 |
|
blood - microbiology |
6 |
|
blood culture |
6 |
|
bmt |
6 |
|
booster vaccine |
6 |
|
bowel preparation |
6 |
|
brain |
6 |
|
bronchi - pathology |
6 |
|
broxyquinoline |
6 |
|
burkholderia infections - etiology - immunology |
6 |
|
cancer |
6 |
|
candida tropicalis fungaemia |
6 |
|
carcinoma |
6 |
|
carnivora - virology |
6 |
|
cat diseases - virology |
6 |
|
cell nucleus - ultrastructure |
6 |
|
cellulitis - microbiology |
6 |
|
chickens - immunology |
6 |
|
cholangiocarcinoma |
6 |
|
cholangitis |
6 |
|
clarithromycin - adverse effects - contraindications |
6 |
|
cloning, molecular - methods |
6 |
|
clr |
6 |
|
co-evolution |
6 |
|
co-immunoprecipitation |
6 |
|
colchicine - adverse effects - contraindications |
6 |
|
common marmoset |
6 |
|
communicable diseases |
6 |
|
community |
6 |
|
computational biology - methods |
6 |
|
coronaviridae - classification - genetics - isolation & purification |
6 |
|
coronavirus - classification - genetics - immunology - isolation & purification |
6 |
|
coronavirus - classification - isolation & purification - ultrastructure |
6 |
|
coronavirus - physiology |
6 |
|
coronavirus 229e, human - immunology |
6 |
|
coronavirus infections - diagnosis - transmission - virology |
6 |
|
coronavirus infections - veterinary - virology |
6 |
|
coronavirus oc43, human - immunology |
6 |
|
cost |
6 |
|
covid-19 vaccine |
6 |
|
coxsackievirus a6 |
6 |
|
cross infection - complications |
6 |
|
cross infection - microbiology |
6 |
|
crossing over, genetic |
6 |
|
crystal structure |
6 |
|
daptomycin |
6 |
|
decolonization |
6 |
|
diagnostic assay |
6 |
|
dimorphic fungus |
6 |
|
disease reservoirs - veterinary - virology |
6 |
|
diverse |
6 |
|
dna vaccine |
6 |
|
dna, bacterial - chemistry - isolation & purification |
6 |
|
dna, ribosomal - chemistry - isolation & purification |
6 |
|
dna, viral - blood |
6 |
|
drug interactions |
6 |
|
drug resistance, microbial |
6 |
|
drug resistance, viral |
6 |
|
drug therapy, combination - therapeutic use |
6 |
|
drug-resistance,-viral-genetics |
6 |
|
ducks - immunology |
6 |
|
elisa |
6 |
|
eltrombopag |
6 |
|
enterovirus 71 |
6 |
|
enterovirus a, human - classification - genetics - isolation & purification |
6 |
|
envelope |
6 |
|
environmental microbiology |
6 |
|
enzymatic immunoassay |
6 |
|
enzyme-linked immunosorbent assay - methods |
6 |
|
eosinophil |
6 |
|
epithelial cells - virology |
6 |
|
escherichia coli proteins |
6 |
|
face mask |
6 |
|
far east - epidemiology |
6 |
|
feces - microbiology |
6 |
|
food contamination - analysis |
6 |
|
gastroenteritis - epidemiology - virology |
6 |
|
geese - immunology |
6 |
|
gene expression regulation, fungal |
6 |
|
gene frequency |
6 |
|
genes, rrna - genetics |
6 |
|
genes, viral - genetics |
6 |
|
genes, viral/ - genetics |
6 |
|
genome subtraction |
6 |
|
genotyping |
6 |
|
giant cells - ultrastructure |
6 |
|
graft vs host disease - immunology |
6 |
|
gram-negative bacteria - classification - genetics - isolation and purification |
6 |
|
gram-positive bacteria - isolation & purification |
6 |
|
gram-positive bacterial infections - epidemiology - microbiology - mortality - physiopathology |
6 |
|
guanosine |
6 |
|
guidelines as topic |
6 |
|
haematological malignancies |
6 |
|
haemorrhagic cystitis |
6 |
|
hand, foot and mouth disease - epidemiology - virology |
6 |
|
hand-foot-and-mouth disease |
6 |
|
health care workers |
6 |
|
heat-shock response - genetics |
6 |
|
hedgehog |
6 |
|
hemagglutinin glycoproteins, influenza virus - chemistry - genetics |
6 |
|
hemagglutinins, viral - metabolism |
6 |
|
hepatitis |
6 |
|
hepatitis b - therapy |
6 |
|
hepatitis b, chronic - genetics |
6 |
|
hepatitis c virus |
6 |
|
hepatitis e |
6 |
|
hev-c1 |
6 |
|
hexachlorophene |
6 |
|
hiv protease inhibitors - therapeutic use |
6 |
|
hla-c antigens - genetics - metabolism |
6 |
|
host-targeted antiviral |
6 |
|
hpyv6 |
6 |
|
hsp90β |
6 |
|
huaiyangshan banyangvirus |
6 |
|
human rhinovirus c |
6 |
|
immune tolerance |
6 |
|
immunoassay - methods |
6 |
|
immunogenicity |
6 |
|
infections |
6 |
|
influenza a virus, h1n1 subtype - genetics - immunology |
6 |
|
influenza a virus, h1n1 subtype - metabolism |
6 |
|
influenza a virus, h5n1 subtype - immunology - isolation & purification |
6 |
|
influenza a virus, h5n1 subtype - isolation & purification |
6 |
|
influenza a virus, h9n2 subtype - genetics - immunology |
6 |
|
influenza in birds - immunology - prevention & control |
6 |
|
influenza vaccines - administration & dosage |
6 |
|
influenza-a-virus,-h5n1-subtype-drug-effects |
6 |
|
influenza-a-virus,-h5n1-subtype-genetics |
6 |
|
infusions, intravenous |
6 |
|
innate immune evasion |
6 |
|
intensive care unit |
6 |
|
interactome |
6 |
|
interferon-gamma - analysis |
6 |
|
interferon-gamma - immunology |
6 |
|
interleukin-4 - analysis |
6 |
|
internal medicine |
6 |
|
intestines - microbiology |
6 |
|
intra-host diversity |
6 |
|
kaletra |
6 |
|
kidney failure - complications |
6 |
|
kidney transplantation |
6 |
|
kidney transplantation - adverse effects |
6 |
|
kinase |
6 |
|
kinetics |
6 |
|
laboratory |
6 |
|
lactobacillus rhamnosus gg |
6 |
|
leptotrichia - classification - genetics - isolation & purification |
6 |
|
leptotrichia hongkongensis |
6 |
|
linezolid |
6 |
|
live-attenuated influenza-based vaccine |
6 |
|
liver disease |
6 |
|
lung - immunology - pathology - virology |
6 |
|
lung - pathology - virology |
6 |
|
macrophages - immunology - virology |
6 |
|
maldi-tof ms |
6 |
|
malignancy |
6 |
|
medical microbiology |
6 |
|
membrane glycoproteins - administration & dosage - genetics - immunology |
6 |
|
memory t cell |
6 |
|
merbecovirus |
6 |
|
metabolic fingerprinting |
6 |
|
metabolites |
6 |
|
metaplasia |
6 |
|
microcephaly |
6 |
|
middle east |
6 |
|
mincle |
6 |
|
mitochondrial dysfunction (md) |
6 |
|
models, animal |
6 |
|
molecular detection |
6 |
|
molecular diagnostic techniques - methods |
6 |
|
molecular modelling |
6 |
|
morbillivirus - pathogenicity |
6 |
|
mortality |
6 |
|
mosquito |
6 |
|
mouth - microbiology |
6 |
|
mp1p-lbd2 |
6 |
|
multigene family - genetics |
6 |
|
mycobacterium tuberculosis - isolation & purification |
6 |
|
mycophenolate |
6 |
|
mycophenolic acid |
6 |
|
mycoses - etiology - immunology |
6 |
|
nasal cavity - virology |
6 |
|
nasal prevention |
6 |
|
nasopharyngeal |
6 |
|
nasopharyngeal swab |
6 |
|
neisseriaceae - isolation & purification |
6 |
|
nephritis, interstitial - virology |
6 |
|
newly-weaned hamster |
6 |
|
next-generation sequencing |
6 |
|
nmr interaction titration |
6 |
|
nose - virology |
6 |
|
nosocomial transmission |
6 |
|
novobiocin |
6 |
|
nsp2 |
6 |
|
nucleic acid amplification |
6 |
|
nucleocapsid proteins - isolation & purification |
6 |
|
ofloxacin |
6 |
|
omacetaxine mepesuccinate |
6 |
|
onychomycosis |
6 |
|
opportunistic infections - diagnosis - transmission - virology |
6 |
|
orthomyxoviridae - genetics - isolation & purification - pathogenicity |
6 |
|
parainfluenza virus |
6 |
|
parainfluenza virus 4, human - classification - genetics - isolation & purification |
6 |
|
paramyxoviridae - classification - genetics - isolation & purification |
6 |
|
paramyxoviridae infections - veterinary - virology |
6 |
|
paramyxovirus |
6 |
|
parvovirus |
6 |
|
patient |
6 |
|
pd1-based dna vaccine |
6 |
|
pediatric |
6 |
|
penicillium - genetics - metabolism |
6 |
|
penicillium - isolation & purification |
6 |
|
pharynx - virology |
6 |
|
picornaviridae - classification - genetics - isolation & purification |
6 |
|
picornaviridae - classification - genetics - isolation and purification |
6 |
|
picornaviridae infections - epidemiology - virology |
6 |
|
platelet transfusion - adverse effects |
6 |
|
pneumocytis |
6 |
|
pneumonia - diagnosis - veterinary - virology |
6 |
|
pneumonia - etiology |
6 |
|
polyethylene glycol |
6 |
|
polymerase inhibitor |
6 |
|
polyomavirus |
6 |
|
poultry - virology |
6 |
|
poultry diseases - prevention & control |
6 |
|
pregnancy complications, infectious - diagnosis - therapy |
6 |
|
premembrane |
6 |
|
primate |
6 |
|
proinflammatory response |
6 |
|
proinflammatory signaling lipid |
6 |
|
promoter regions, genetic - genetics |
6 |
|
psoas abscess - microbiology |
6 |
|
public health |
6 |
|
pulse therapy, drug |
6 |
|
pyrimidinones - therapeutic use |
6 |
|
quarantine - veterinary |
6 |
|
rapid diagnosis |
6 |
|
rat hepatitis e |
6 |
|
reagent kits, diagnostic |
6 |
|
real time rt-pcr |
6 |
|
realstar® adenovirus pcr kit |
6 |
|
reassortant viruses - genetics - isolation & purification - pathogenicity |
6 |
|
receptors, virus - genetics - metabolism |
6 |
|
regorafenib |
6 |
|
renal transplant |
6 |
|
respiratory syncytial virus |
6 |
|
reverse transcriptase polymerase chain reaction - methods - standards |
6 |
|
rhinovirus - classification - genetics - isolation and purification |
6 |
|
ribavirin |
6 |
|
rimantadine-pharmacology |
6 |
|
ritonavir - therapeutic use |
6 |
|
rlr |
6 |
|
rna, viral |
6 |
|
rna, viral - analysis - isolation & purification |
6 |
|
rna, viral - chemistry |
6 |
|
rna, viral - genetics - isolation & purification |
6 |
|
rodent |
6 |
|
rodents |
6 |
|
rt-lamp |
6 |
|
sarbecovirus |
6 |
|
sars virus - classification - genetics |
6 |
|
sars virus - classification - genetics - immunology - isolation & purification |
6 |
|
sars virus - genetics - immunology - isolation & purification |
6 |
|
sars virus - pathogenicity |
6 |
|
sars-cov-1 |
6 |
|
seasonality |
6 |
|
seizure |
6 |
|
sepsis |
6 |
|
sequence deletion |
6 |
|
severe acute respiratory syndrome - blood - immunology |
6 |
|
severe acute respiratory syndrome - complications - immunology |
6 |
|
severe acute respiratory syndrome - complications - pathology - virology |
6 |
|
severe acute respiratory syndrome - diagnosis - drug therapy - epidemiology - virology |
6 |
|
severe acute respiratory syndrome - diagnosis - epidemiology - virology |
6 |
|
severe acute respiratory syndrome - diagnosis - immunology |
6 |
|
severe acute respiratory syndrome - diagnosis - immunology - virology |
6 |
|
severe acute respiratory syndrome - diagnosis - transmission - virology |
6 |
|
severe acute respiratory syndrome - diagnosis - urine |
6 |
|
severe acute respiratory syndrome - drug therapy - virology |
6 |
|
severe acute respiratory syndrome - epidemiology - microbiology |
6 |
|
severe acute respiratory syndrome - epidemiology - virology |
6 |
|
severe acute respiratory syndrome - prevention & control |
6 |
|
sfstv |
6 |
|
shewanella - classification - drug effects - isolation & purification - pathogenicity |
6 |
|
songbirds - virology |
6 |
|
spa type |
6 |
|
species |
6 |
|
specimen handling |
6 |
|
streptococcal infections |
6 |
|
streptococcal infections - microbiology |
6 |
|
streptococcus - classification - genetics - isolation & purification |
6 |
|
structural evolution |
6 |
|
syto9 |
6 |
|
t-cell functionality |
6 |
|
tetrapeptide |
6 |
|
tick |
6 |
|
tract |
6 |
|
transmissibility |
6 |
|
transmission dynamics |
6 |
|
triclosan |
6 |
|
tuberculosis |
6 |
|
tuhokovirus |
6 |
|
vaccination - veterinary |
6 |
|
vaccine seed strain selection |
6 |
|
vaccines, synthetic - administration & dosage - immunology |
6 |
|
vancomycin resistance |
6 |
|
viral envelope proteins - administration & dosage - genetics - immunology |
6 |
|
viral hepatitis |
6 |
|
viral load - statistics & numerical data |
6 |
|
viral proteins - genetics - metabolism |
6 |
|
viral structural proteins - genetics |
6 |
|
viremia - diagnosis - epidemiology |
6 |
|
virulence mechanism |
6 |
|
virus attachment |
6 |
|
virus discovery |
6 |
|
whole genome |
6 |
|
wuhan |
6 |
|
zoonoses - epidemiology |
6 |
|
16s rdna gene |
5 |
|
3c-like protease |
5 |
|
abbott real time hcv genotype ii |
5 |
|
acetic acid |
5 |
|
acquired immunodeficiency syndrome - complications - diagnosis |
5 |
|
actinomyces - classification - cytology - isolation & purification - physiology |
5 |
|
actinomyces hongkongensis |
5 |
|
actinomycetales - genetics - isolation & purification |
5 |
|
actinomycetales - isolation & purification |
5 |
|
actinomycetales infections - diagnosis - microbiology |
5 |
|
actinomycetales infections - microbiology |
5 |
|
actinomycosis - microbiology |
5 |
|
actins - genetics |
5 |
|
acyclovir - therapeutic use |
5 |
|
adaptation, biological |
5 |
|
adeno-associated virus |
5 |
|
adenosine deaminase |
5 |
|
adrenal cortex hormones - administration and dosage - adverse effects |
5 |
|
agar block smear |
5 |
|
aichi virus |
5 |
|
alere i flu a & b |
5 |
|
allogeneic stem cell transplantation |
5 |
|
alphacoronavirus |
5 |
|
alveolar-bronchiolization |
5 |
|
amniotomy |
5 |
|
anaerobic bacterium |
5 |
|
anaerobiosis |
5 |
|
animals, domestic - virology |
5 |
|
antibiotic sensitivity |
5 |
|
antibiotic susceptibility |
5 |
|
antibody affinity |
5 |
|
antigens, viral - analysis - immunology |
5 |
|
antigens, viral - blood |
5 |
|
antigens, viral, tumor - genetics - immunology |
5 |
|
antimicrobial agents/inhibitors |
5 |
|
antitubercular agents - pharmacology |
5 |
|
arachidonic acid (aa) |
5 |
|
arthralgia |
5 |
|
arthritis |
5 |
|
asia |
5 |
|
asian continental ancestry group - genetics |
5 |
|
aspergillosis - etiology |
5 |
|
aspergillus - isolation & purification |
5 |
|
astroviridae - classification - genetics - isolation and purification |
5 |
|
astroviridae infections - veterinary - virology |
5 |
|
avian influenza virus h5n1 clade 2.3.4.4b |
5 |
|
b-lymphocytes - cytology - immunology - metabolism |
5 |
|
b.1.1.7b.1.351 |
5 |
|
bacteremia - complications - epidemiology - etiology |
5 |
|
bacteria |
5 |
|
bacteria (microorganisms) |
5 |
|
bacteria - classification - genetics |
5 |
|
bacteria - classification - genetics - isolation & purification |
5 |
|
bacteria - isolation & purification |
5 |
|
bacteria, aerobic - classification - genetics |
5 |
|
bacteria, anaerobic - classification - genetics |
5 |
|
bacterial endocarditis |
5 |
|
bacterial infections - diagnosis - microbiology |
5 |
|
bacterial infections - microbiology |
5 |
|
bacterial typing techniques - methods |
5 |
|
bacteriuria |
5 |
|
basal cell |
5 |
|
bats |
5 |
|
beta-lactamases - analysis |
5 |
|
beta-lactamases - biosynthesis - genetics |
5 |
|
beta-lactamases - chemistry - genetics |
5 |
|
birds |
5 |
|
bk virus - genetics - immunology - pathogenicity |
5 |
|
bk virus - isolation & purification - physiology |
5 |
|
bk virus nephropathy |
5 |
|
blood platelets - microbiology |
5 |
|
bone marrow - pathology |
5 |
|
bone marrow transplant |
5 |
|
booster |
5 |
|
broad-spectrum antivirals |
5 |
|
calibration |
5 |
|
caliciviridae infections - epidemiology - prevention and control - transmission |
5 |
|
california sea lions |
5 |
|
campylobacter fetus - classification - genetics - growth & development - isolation & purification |
5 |
|
campylobacter infections - microbiology |
5 |
|
cardio-renal metabolic syndrome |
5 |
|
catalase |
5 |
|
catheterization - adverse effects |
5 |
|
ccl22 |
5 |
|
cell movement - immunology |
5 |
|
cell nucleus - genetics |
5 |
|
characterization |
5 |
|
chemokine cxcl13 - biosynthesis - immunology |
5 |
|
chinese horseshoe bats |
5 |
|
cholecystitis - microbiology |
5 |
|
chromobacterium violaceum |
5 |
|
ciprofloxacin - pharmacology - therapeutic use |
5 |
|
ciprofloxacin - therapeutic use |
5 |
|
circrna |
5 |
|
clostridium difficile - classification - genetics - isolation and purification |
5 |
|
cmv |
5 |
|
cofactors |
5 |
|
communicable diseases - classification |
5 |
|
communicable diseases, emerging |
5 |
|
communicable diseases, emerging - microbiology |
5 |
|
community-acquired infections - microbiology |
5 |
|
competing endogenous rna |
5 |
|
complication |
5 |
|
construction strategies |
5 |
|
contact examination |
5 |
|
coronaviridae - chemistry - classification - genetics - isolation and purification |
5 |
|
covid-19 severity |
5 |
|
coxiella burnetii |
5 |
|
cross infection - diagnosis - epidemiology - virology |
5 |
|
cross infection - epidemiology - prevention and control - transmission |
5 |
|
cross infection - microbiology - prevention and control - transmission |
5 |
|
cross infection - prevention and control - transmission - virology |
5 |
|
cryptococcosis - diagnosis - etiology |
5 |
|
cytomegalovirus - drug effects - genetics - isolation & purification |
5 |
|
cytomegalovirus - genetics - immunology - pathogenicity |
5 |
|
cytomegalovirus infections - immunology - virology |
5 |
|
databases, nucleic acid |
5 |
|
deltacoronavirus |
5 |
|
diagnostic errors |
5 |
|
discitis - diagnosis - drug therapy |
5 |
|
disease outbreaks - prevention and control - statistics and numerical data |
5 |
|
disease susceptibility |
5 |
|
disinfection |
5 |
|
dna, bacterial |
5 |
|
dna, complementary - analysis |
5 |
|
dna, mitochondrial - genetics |
5 |
|
dna, protozoan - blood - genetics |
5 |
|
dna, ribosomal |
5 |
|
dna, ribosomal - analysis - genetics |
5 |
|
dna, ribosomal - genetics |
5 |
|
dna, viral - analysis - genetics |
5 |
|
dna, viral - blood - drug effects |
5 |
|
dog diseases - microbiology |
5 |
|
drug dosage form comparison |
5 |
|
drug dose comparison |
5 |
|
drug resistance, multiple, bacterial - genetics |
5 |
|
drug resistance, viral - genetics |
5 |
|
electrophoresis, gel, pulsed-field - methods |
5 |
|
emergency service, hospital |
5 |
|
emerging infectious disease |
5 |
|
empyema, pleural - microbiology |
5 |
|
encephalities |
5 |
|
endocarditis, bacterial |
5 |
|
endocarditis, bacterial - microbiology |
5 |
|
enterocolitis, pseudomembranous - epidemiology - microbiology |
5 |
|
enterovirus - classification - genetics - isolation and purification |
5 |
|
erythromycin - pharmacology |
5 |
|
escherichia coli - drug effects - genetics - metabolism |
5 |
|
escherichia coli - genetics - metabolism |
5 |
|
expression |
5 |
|
falcon |
5 |
|
famotidine - pharmacology |
5 |
|
fecal-to-oral transmission |
5 |
|
fever - etiology - therapy |
5 |
|
fever - microbiology |
5 |
|
fluoroquinolones |
5 |
|
food contamination |
5 |
|
fresh water - microbiology |
5 |
|
fungi |
5 |
|
fusarium |
5 |
|
gene components - genetics |
5 |
|
gene expression profiling |
5 |
|
gene expression regulation |
5 |
|
genes - genetics |
5 |
|
genes, fungal |
5 |
|
genetic variation - genetics |
5 |
|
genogroup |
5 |
|
genogroup i |
5 |
|
gentian violet |
5 |
|
glucose homeostasis |
5 |
|
glutathione transferase - genetics - metabolism |
5 |
|
gout - microbiology |
5 |
|
graft vs host disease |
5 |
|
gram-negative bacterial infections - microbiology |
5 |
|
gram-positive bacteria - classification - genetics |
5 |
|
gram-positive bacterial infections - diagnosis - drug therapy |
5 |
|
gram-positive cocci |
5 |
|
green fluorescent proteins - genetics - metabolism |
5 |
|
guinea pigs |
5 |
|
h1n1 virus |
5 |
|
h5n1 influenza virus |
5 |
|
h9n2 |
5 |
|
haemophilus - classification - genetics - isolation & purification |
5 |
|
haplorhini |
5 |
|
haplotypes |
5 |
|
hepatitis b, chronic - genetics - virology |
5 |
|
hepatitis c |
5 |
|
herpes simplex virus 2 |
5 |
|
herpesviridae |
5 |
|
herpesviridae infections - blood - drug therapy - etiology |
5 |
|
herpesvirus 6, human - drug effects - genetics - isolation & purification |
5 |
|
herpesvirus 7, human - drug effects - genetics - isolation & purification |
5 |
|
histamine h2 antagonists - pharmacology |
5 |
|
hiv-1 |
5 |
|
hku2 |
5 |
|
hnpcs |
5 |
|
horses |
5 |
|
hot temperature |
5 |
|
houbara bustard |
5 |
|
human alphaherpesvirus 1 |
5 |
|
human coronavirus |
5 |
|
human coronaviruses |
5 |
|
human parechovirus |
5 |
|
hybrid immunity |
5 |
|
identification |
5 |
|
ifngr1 |
5 |
|
il-17 |
5 |
|
immunization, passive |
5 |
|
immunoglobulins |
5 |
|
immunological comparison |
5 |
|
immunosuppressive agents - administration & dosage |
5 |
|
implant |
5 |
|
inducible |
5 |
|
infection control bundle |
5 |
|
influenza a virus - genetics - isolation & purification |
5 |
|
influenza a virus, h1n1 subtype - classification - genetics - isolation & purification |
5 |
|
influenza a virus, h1n1 subtype - genetics - isolation & purification |
5 |
|
influenza a virus, h1n1 subtype - immunology - isolation and purification - pathogenicity |
5 |
|
influenza a virus, h2n2 subtype - classification - genetics - isolation & purification |
5 |
|
influenza a virus, h3n2 subtype - classification - genetics - isolation & purification |
5 |
|
influenza a virus, h3n2 subtype - genetics - isolation and purification |
5 |
|
influenza a virus, h5n1 subtype - classification - genetics - isolation & purification |
5 |
|
influenza a virus, h7n9 subtype - genetics - isolation and purification |
5 |
|
influenza vaccines |
5 |
|
influenza, human - mortality - therapy - virology |
5 |
|
influenza, human - prevention and control - transmission - virology |
5 |
|
injections, intravenous |
5 |
|
inpatients |
5 |
|
interleukin-17 - deficiency - genetics - immunology |
5 |
|
interspecies jumping |
5 |
|
invasive infections |
5 |
|
isolation |
5 |
|
isoniazid - pharmacology |
5 |
|
its sequencing |
5 |
|
keratitis - microbiology |
5 |
|
kidney calculi - etiology - urine |
5 |
|
kidney failure, chronic - surgery |
5 |
|
kytococcus schroeteri |
5 |
|
lactococcus - classification - genetics - pathogenicity |
5 |
|
leukemia |
5 |
|
leukocytes, mononuclear - virology |
5 |
|
library |
5 |
|
likelihood functions |
5 |
|
lipid-protein interaction |
5 |
|
lipocalin-2 |
5 |
|
live oral vaccine |
5 |
|
liver - pathology - virology |
5 |
|
logistic models |
5 |
|
long covid-19 |
5 |
|
longitudinal studies |
5 |
|
luciferases - genetics - metabolism |
5 |
|
luminescent measurements |
5 |
|
luminex nxtag |
5 |
|
lung infection |
5 |
|
lymphatic diseases - diagnosis - etiology |
5 |
|
lymphocyte count |
5 |
|
lymphoma - diagnosis |
5 |
|
magnetic resonance imaging |
5 |
|
malaria - diagnosis - parasitology |
5 |
|
malaria, falciparum - blood - diagnosis |
5 |
|
mammals |
5 |
|
medical sciences biology |
5 |
|
metabolic profiling |
5 |
|
mice, knockout |
5 |
|
mice, transgenic |
5 |
|
microarray analysis - methods |
5 |
|
mirna |
5 |
|
mitochondria |
5 |
|
mitochondria - genetics |
5 |
|
mitochondrial genome |
5 |
|
molecular |
5 |
|
molecular diagnostic techniques - economics - methods |
5 |
|
mrna |
5 |
|
mucorales |
5 |
|
multiplex real time polymerase chain reaction |
5 |
|
mycobacterium infections - etiology - microbiology |
5 |
|
mycobacterium tuberculosis - drug effects - genetics - isolation & purification |
5 |
|
myeloperoxidase |
5 |
|
myelosuppression |
5 |
|
nasopharyngeal specimen |
5 |
|
neisseria gonorrhoeae |
5 |
|
neisseria meningitidis |
5 |
|
neisseriaceae - classification - genetics - isolation & purification |
5 |
|
neisseriaceae - classification - genetics - isolation and purification |
5 |
|
neisseriaceae - genetics - isolation & purification - metabolism |
5 |
|
neisseriaceae infections - microbiology |
5 |
|
neisseriaceae infections - microbiology - transmission |
5 |
|
nephritis, interstitial - diagnosis - virology |
5 |
|
neutralizing antibody spike protein receptor binding domain |
5 |
|
nmr-based urinalysis |
5 |
|
nontuberculous mycobacterium |
5 |
|
norovirus - genetics - isolation and purification |
5 |
|
noroviruses |
5 |
|
north america |
5 |
|
nose - microbiology |
5 |
|
nosocomial infection |
5 |
|
novel virus |
5 |
|
ns1 |
5 |
|
ns5 protein |
5 |
|
nuclear magnetic resonance |
5 |
|
odds ratio |
5 |
|
opportunistic infections - immunology - virology |
5 |
|
oral dna vaccination |
5 |
|
origin |
5 |
|
orthomyxoviridae infections - diagnosis - virology |
5 |
|
orthomyxoviridae infections - immunology - mortality - pathology - virology |
5 |
|
oseltamivir - pharmacology |
5 |
|
osteomyelitis |
5 |
|
osteomyelitis - microbiology |
5 |
|
pasc |
5 |
|
pathology |
5 |
|
patient isolation - methods |
5 |
|
pelvic actinomycosis |
5 |
|
pelvic inflammatory disease - microbiology |
5 |
|
penicillium - classification - genetics |
5 |
|
phaeoacremonium parasiticum |
5 |
|
phenazines |
5 |
|
picobirnaviruses |
5 |
|
picornaviridae infections - veterinary - virology |
5 |
|
plasmodium falciparum - genetics - isolation & purification |
5 |
|
plasmodium malariae - genetics - isolation and purification |
5 |
|
point-of-care systems |
5 |
|
polyamination |
5 |
|
polymerase chain reaction - economics - methods - standards |
5 |
|
polyomavirus infections - diagnosis - etiology |
5 |
|
polyomavirus infections - prevention & control - virology |
5 |
|
polysaccharides, bacterial - biosynthesis |
5 |
|
population susceptibility |
5 |
|
prisma |
5 |
|
promoter activity |
5 |
|
prosthesis-related infections - microbiology |
5 |
|
protein stability |
5 |
|
proteobacteria - enzymology - genetics |
5 |
|
pulmonology |
5 |
|
pyoderma - microbiology - veterinary |
5 |
|
pyrimidine synthesis inhibitor |
5 |
|
quantitative rt-pcr |
5 |
|
rabbits - virology |
5 |
|
rapid molecular test |
5 |
|
receptor |
5 |
|
receptor, interferon alpha-beta - biosynthesis - genetics |
5 |
|
receptors, cxcr5 - biosynthesis - immunology |
5 |
|
receptors, interferon - genetics |
5 |
|
recombinant |
5 |
|
recombinant proteins - immunology |
5 |
|
reference standards |
5 |
|
referral and consultation |
5 |
|
renal abscess |
5 |
|
respiratory tract infections - etiology - microbiology |
5 |
|
reverse transcriptase polymerase chain reaction - economics - methods |
5 |
|
review |
5 |
|
ribavirin - therapeutic use |
5 |
|
ribotype 027 |
5 |
|
ribotyping |
5 |
|
rna virus |
5 |
|
rna, bacterial - analysis |
5 |
|
rna, ribosomal, 16s - analysis |
5 |
|
rna, ribosomal, 16s - analysis - genetics |
5 |
|
rna, ribosomal, 16s - chemistry - genetics |
5 |
|
rna, ribosomal, 18s - genetics |
5 |
|
rna, transfer - genetics |
5 |
|
rna, viral - analysis - genetics - isolation & purification |
5 |
|
rubulavirus infections - diagnosis - epidemiology - virology |
5 |
|
rubulavirus infections - epidemiology - virology |
5 |
|
s. aureus |
5 |
|
salivirus |
5 |
|
salmonella typhimurium |
5 |
|
salmonella typhimurium - genetics |
5 |
|
sars virus - genetics - growth & development - isolation & purification |
5 |
|
sars virus - metabolism |
5 |
|
sars-cov-2 n501y variant |
5 |
|
sea lion |
5 |
|
selection |
5 |
|
sequence analysis, dna - standards |
5 |
|
sequence analysis, rna |
5 |
|
sequence analysis, rna - methods |
5 |
|
seroepidemiological study |
5 |
|
serosurveillance |
5 |
|
severe acute respiratory syndrome - blood - mortality - virology |
5 |
|
severe acute respiratory syndrome - diagnosis - epidemiology - prevention & control - transmission - virology |
5 |
|
shuttle vector |
5 |
|
smell training |
5 |
|
soluble and insoluble antigens |
5 |
|
specimen handling - methods |
5 |
|
spectrometry, mass, matrix-assisted laser desorption-ionization |
5 |
|
spores, bacterial |
5 |
|
staphylococcal infections - microbiology - prevention and control - transmission |
5 |
|
staphylococcal skin infections - microbiology - veterinary |
5 |
|
staphylococcus - classification - genetics |
5 |
|
staphylococcus - genetics |
5 |
|
staphylococcus aureus - classification - drug effects - isolation & purification |
5 |
|
stat1 |
5 |
|
stat2 |
5 |
|
streptococcal infections - diagnosis - microbiology |
5 |
|
streptococcal infections - epidemiology - microbiology |
5 |
|
streptococcus - classification - isolation & purification |
5 |
|
streptococcus - classification - isolation & purification - pathogenicity - physiology |
5 |
|
streptococcus iniae |
5 |
|
t cell |
5 |
|
tomography, x-ray computed |
5 |
|
transformation, bacterial |
5 |
|
transformation, genetic |
5 |
|
transplantation, homologous |
5 |
|
triazines - analysis - chemistry - urine |
5 |
|
trimethylamine |
5 |
|
tuberculosis, pulmonary - diagnosis - drug therapy - microbiology |
5 |
|
tumor virus infections - diagnosis - etiology |
5 |
|
tumor virus infections - prevention & control - virology |
5 |
|
type ii interferon |
5 |
|
urinary tract infection |
5 |
|
viral envelope proteins - genetics |
5 |
|
viral envelope proteins - immunology |
5 |
|
viral persistence |
5 |
|
viridans streptococci - classification - cytology - immunology - physiology |
5 |
|
voc |
5 |
|
water microbiology |
5 |
|
weight loss |
5 |
|
wireless sensor networks |
5 |
|
x-ray crystallography |
5 |
|
xpert xpress flu/rsv |
5 |
|
yeasts - genetics |
5 |
|
β-tubulin gene sequencing |
5 |
|
16s rrna, groel |
4 |
|
abscess - diagnosis - microbiology |
4 |
|
abscess - microbiology |
4 |
|
acinetobacter - genetics |
4 |
|
acinetobacter - isolation & purification - metabolism |
4 |
|
acinetobacter-infections-epidemiology |
4 |
|
acinetobacter-isolation-and-purification |
4 |
|
actinobacteria - classification - genetics - isolation & purification - physiology |
4 |
|
acupuncture |
4 |
|
acute cholecystitis |
4 |
|
acyl-coa dehydrogenase - genetics - metabolism |
4 |
|
adaptor proteins, signal transducing - metabolism |
4 |
|
adenocarcinoma - complications - diagnosis - therapy |
4 |
|
adenolymphoma - complications - microbiology |
4 |
|
adenoviridae - genetics - isolation & purification |
4 |
|
adenoviridae - isolation & purification |
4 |
|
adenoviridae - physiology |
4 |
|
adenoviridae infections - etiology - pathology |
4 |
|
adenovirus infections, human - diagnosis - virology |
4 |
|
adenoviruses, human - genetics - isolation and purification |
4 |
|
adenoviruses, human - isolation and purification |
4 |
|
adhesion factor |
4 |
|
adoptive immune transfer |
4 |
|
adsa |
4 |
|
aerobiosis |
4 |
|
agar gel electrophoresis |
4 |
|
aids-related opportunistic infections - diagnosis |
4 |
|
alemtuzumab |
4 |
|
algorithms |
4 |
|
alkanindiges hongkongensis |
4 |
|
ampicillin - therapeutic use |
4 |
|
anaerospora hongkongensis |
4 |
|
anaplasma platys |
4 |
|
ancylostoma duodenale |
4 |
|
animal rna viruses |
4 |
|
anisakis simplex |
4 |
|
anti-bacterial agents - administration & dosage - pharmacology - toxicity |
4 |
|
anti-bacterial agents - administration & dosage - therapeutic use |
4 |
|
anti-infective agents - pharmacology |
4 |
|
anti-infective agents - therapeutic use |
4 |
|
antibiotics |
4 |
|
antibodies |
4 |
|
antibodies, bacterial - blood - immunology |
4 |
|
antibodies, fungal - blood |
4 |
|
antibodies, fungal - blood - diagnostic use - immunology |
4 |
|
antibodies, fungal - immunology |
4 |
|
antibodies, monoclonal - administration & dosage - adverse effects |
4 |
|
antibodies, monoclonal, humanized |
4 |
|
antibodies, neoplasm - administration & dosage - adverse effects |
4 |
|
antibodies, viral - analysis |
4 |
|
antigen detection |
4 |
|
antigens - genetics - metabolism |
4 |
|
antigens, bacterial |
4 |
|
antigens, bacterial - genetics - immunology |
4 |
|
antigens, fungal - analysis - blood - immunology |
4 |
|
antigens, fungal - genetics |
4 |
|
antigens, fungal - genetics - immunology |
4 |
|
antimicrobial resistance |
4 |
|
antineoplastic agents - administration & dosage - adverse effects |
4 |
|
antineoplastic agents - adverse effects |
4 |
|
antitubercular agents - administration & dosage |
4 |
|
antiviral therapy |
4 |
|
anura - microbiology |
4 |
|
aortic aneurysm, abdominal - complications - diagnosis - pathology - therapy |
4 |
|
appendectomy |
4 |
|
appendicitis - microbiology - pathology |
4 |
|
appendix perforation |
4 |
|
arcobacter - classification - isolation & purification |
4 |
|
arthritis, reactive - complications - microbiology |
4 |
|
ascariasis - diagnosis |
4 |
|
ascaris lumbricoides |
4 |
|
ascomycota - genetics - isolation & purification |
4 |
|
asian continental ancestry group |
4 |
|
aspergillosis - diagnosis - microbiology |
4 |
|
aspergillus flavus - genetics - immunology - metabolism |
4 |
|
aspergillus fumigatus - chemistry - immunology - isolation & purification |
4 |
|
aspergillus fumigatus - genetics - immunology |
4 |
|
astrocytes - virology |
4 |
|
autoimmune diseases - blood - complications - drug therapy - virology |
4 |
|
avian influenza a virus |
4 |
|
azithromycin - therapeutic use |
4 |
|
ba.2.86 |
4 |
|
babesia |
4 |
|
bacillaceae - genetics - isolation & purification - ultrastructure |
4 |
|
bacteremia - diagnosis - drug therapy - microbiology |
4 |
|
bacteremia - drug therapy - etiology - mortality |
4 |
|
bacteremia - drug therapy - microbiology |
4 |
|
bacteremia - epidemiology |
4 |
|
bacteremia-epidemiology |
4 |
|
bacterial infections - diagnosis - drug therapy - epidemiology |
4 |
|
bacterial outer membrane proteins - genetics |
4 |
|
bacterial proteins - genetics - metabolism |
4 |
|
bacterium culture |
4 |
|
bactrian came |
4 |
|
beta-lactamases - biosynthesis |
4 |
|
beta-lactamases - genetics - metabolism |
4 |
|
biliary tract diseases |
4 |
|
binding sites - genetics |
4 |
|
bk virus - genetics - isolation & purification |
4 |
|
bk virus - physiology |
4 |
|
blood sampling |
4 |
|
bone marrow transplantation - adverse effects - immunology |
4 |
|
bone marrow transplantation - adverse effects - methods - pathology |
4 |
|
bone marrow transplantation -immunology |
4 |
|
brain diseases - microbiology |
4 |
|
broad-spectrum antiviral drugs |
4 |
|
bronchoalveolar lavage fluid - microbiology |
4 |
|
burkholderia - classification - genetics |
4 |
|
burkholderia pseudomallei - classification - genetics - immunology |
4 |
|
burkholderia pseudomallei - genetics - isolation & purification |
4 |
|
busulfan - adverse effects - therapeutic use |
4 |
|
caliciviridae infections - genetics |
4 |
|
caliciviridae infections - veterinary - virology |
4 |
|
capnocytophaga - isolation and purification |
4 |
|
capping phenomenon |
4 |
|
carbapenem-resistant acinetobacter species |
4 |
|
carbapenemase-producing enterobacteriaceae |
4 |
|
cardiac complications |
4 |
|
carps - microbiology |
4 |
|
carrier proteins - analysis |
4 |
|
catalase - analysis |
4 |
|
catheterization, central venous - adverse effects |
4 |
|
catheters, indwelling - adverse effects |
4 |
|
ccaat-enhancer-binding proteins - metabolism |
4 |
|
cd4-cd8 ratio |
4 |
|
cd8-positive t-lymphocytes - immunology - virology |
4 |
|
cecal diseases - diagnosis - parasitology |
4 |
|
cefoperazone - pharmacology |
4 |
|
cefotaxime/adverse effects |
4 |
|
cell death |
4 |
|
cell wall - chemistry |
4 |
|
cell wall - chemistry - immunology |
4 |
|
cells, cultured |
4 |
|
cellular immune response |
4 |
|
central venous catheter |
4 |
|
cephalosporin resistance |
4 |
|
cercopithecus aethiops |
4 |
|
cerebrospinal fluid |
4 |
|
chaperonin 60 - analysis |
4 |
|
chaperonin 60 - chemistry |
4 |
|
child day care centers |
4 |
|
chinese tiger frog |
4 |
|
cholangitis - microbiology |
4 |
|
chronic hbv infection |
4 |
|
chronic infection |
4 |
|
clade a |
4 |
|
clarithromycin - administration & dosage - pharmacology - toxicity |
4 |
|
clarithromycin - pharmacology |
4 |
|
class iii pi3-k |
4 |
|
cleavage of s protein |
4 |
|
clinical |
4 |
|
clinical laboratory |
4 |
|
cloaca - microbiology |
4 |
|
clonorchiasis |
4 |
|
codon - genetics |
4 |
|
codon usage |
4 |
|
colonic carcinoma |
4 |
|
colonic neoplasms - complications - diagnosis - therapy |
4 |
|
colonization |
4 |
|
communicable disease control |
4 |
|
communicable diseases public health and safety |
4 |
|
communicable diseases, emerging - epidemiology - virology |
4 |
|
community-acquired gastroenteritis |
4 |
|
community-acquired infections - epidemiology - microbiology |
4 |
|
community-acquired infections - epidemiology - microbiology - physiopathology |
4 |
|
community-acquired infections - virology |
4 |
|
complications |
4 |
|
computational biology |
4 |
|
conjunctivitis |
4 |
|
conjunctivitis - virology |
4 |
|
consensus sequence |
4 |
|
conserved sequence |
4 |
|
consumer product safety |
4 |
|
contact tracing |
4 |
|
coronavirus - genetics |
4 |
|
coronavirus infections - epidemiology - veterinary - virology |
4 |
|
coronavirus infections - epidemiology - virology |
4 |
|
cpg island |
4 |
|
cross infection - epidemiology - microbiology |
4 |
|
cryptococcosis - blood - chemically induced |
4 |
|
culture |
4 |
|
culture media, conditioned - chemistry |
4 |
|
cyanuric acid |
4 |
|
cysteine endopeptidases - metabolism |
4 |
|
cystitis - diagnosis - etiology - virology |
4 |
|
cystitis - etiology - pathology - urine - virology |
4 |
|
cytomegalovirus - genetics - isolation & purification |
4 |
|
cytomegalovirus infections - blood - chemically induced - prevention & control |
4 |
|
cytomegalovirus infections - blood - diagnosis - epidemiology |
4 |
|
cytomegalovirus reactivation |
4 |
|
cytotoxic t cell |
4 |
|
cytotoxicity, immunologic |
4 |
|
dependovirus |
4 |
|
dermatomycoses - microbiology |
4 |
|
diagnostic test evaluation |
4 |
|
diarrhea - drug therapy - epidemiology - microbiology |
4 |
|
differential gene expression |
4 |
|
dimorphic |
4 |
|
dirofilaria immitis |
4 |
|
disease models, animal |
4 |
|
disease surveillance |
4 |
|
distribution |
4 |
|
dna base composition |
4 |
|
dna gyrase - chemistry - genetics |
4 |
|
dna helicases - genetics |
4 |
|
dna primers - genetics |
4 |
|
dna probes - genetics |
4 |
|
dna, fungal - analysis |
4 |
|
dna, recombinant - administration & dosage |
4 |
|
dna, ribosomal - chemistry |
4 |
|
dna, viral - analysis |
4 |
|
dna, viral - genetics - isolation & purification |
4 |
|
dna-binding proteins - genetics |
4 |
|
dna-binding proteins - genetics - metabolism |
4 |
|
dog |
4 |
|
dromedary camels |
4 |
|
drug repurposing |
4 |
|
drug resistance, multiple, bacterial |
4 |
|
drug therapy |
4 |
|
ecosystem |
4 |
|
eg.5 |
4 |
|
ehrlichia |
4 |
|
electron transport complex iv - analysis |
4 |
|
eliminated non-coding orfs |
4 |
|
endemicity |
4 |
|
endocarditis |
4 |
|
endocarditis, bacterial - complications - diagnosis - therapy |
4 |
|
endocarditis, bacterial - diagnosis - microbiology |
4 |
|
endoplasmic reticulum - metabolism |
4 |
|
enterococcus faecium - isolation & purification |
4 |
|
epithelial cells - metabolism |
4 |
|
epitope |
4 |
|
epstein-barr virus |
4 |
|
esbl-producing enterobacterales |
4 |
|
escherichia coli - drug effects - enzymology - isolation & purification |
4 |
|
escherichia coli - genetics |
4 |
|
escherichia coli infections - microbiology |
4 |
|
evolution |
4 |
|
ex vivo human lung tissues |
4 |
|
extended-spectrum β-lactamases |
4 |
|
extracellular |
4 |
|
factor xa - metabolism |
4 |
|
fade28 |
4 |
|
fatty acids - analysis |
4 |
|
feces |
4 |
|
fishes |
4 |
|
fluoroquinolones - pharmacology |
4 |
|
foot and mouth disease |
4 |
|
freshwater fish |
4 |
|
fungal proteins - genetics |
4 |
|
fungal proteins - genetics - immunology - isolation & purification |
4 |
|
fungemia - blood - chemically induced |
4 |
|
fungemia - etiology - mortality |
4 |
|
fungi - isolation and purification |
4 |
|
fungus |
4 |
|
gallstones - complications - diagnosis - microbiology |
4 |
|
gastroenteritis - drug therapy - epidemiology - microbiology |
4 |
|
gastroenteritis - virology |
4 |
|
gastrointestinal colonization |
4 |
|
gene amplification |
4 |
|
gene expression |
4 |
|
gene expression regulation - immunology |
4 |
|
gene expression regulation, viral |
4 |
|
gene expression regulation, viral - immunology |
4 |
|
gene therapy |
4 |
|
genes,-rrna |
4 |
|
genomic rearrangement |
4 |
|
genotype 6 |
4 |
|
gills - microbiology |
4 |
|
glucose - metabolism |
4 |
|
glutamine |
4 |
|
glyceraldehyde-3-phosphate dehydrogenase |
4 |
|
graft vs host disease - complications - immunology |
4 |
|
gram-negative bacterial infections - diagnosis |
4 |
|
gram-negative bacterial infections - diagnosis - epidemiology |
4 |
|
gram-negative bacterial infections - drug therapy - etiology |
4 |
|
gram-negative bacterial infections - epidemiology - microbiology |
4 |
|
gram-positive bacteria - classification - isolation & purification |
4 |
|
gram-positive bacterial infections - diagnosis - drug therapy - microbiology |
4 |
|
gram-positive bacterial infections - diagnosis - microbiology |
4 |
|
gram-positive bacterial infections - microbiology - veterinary |
4 |
|
h10n8 |
4 |
|
h5n1 subtype |
4 |
|
haemophilus infections |
4 |
|
hand |
4 |
|
hand foot and mouth disease |
4 |
|
hbv |
4 |
|
heat-shock proteins - metabolism |
4 |
|
hematopoietic stem cell transplantation - adverse effects - methods |
4 |
|
hematopoietic stem cells - immunology |
4 |
|
hematuria - diagnosis - etiology - virology |
4 |
|
hemorrhage - etiology - pathology - surgery - virology |
4 |
|
hepatitis b antibodies - biosynthesis |
4 |
|
hepatitis b antibodies - biosynthesis - blood - immunology |
4 |
|
hepatitis b antigens - metabolism |
4 |
|
hepatitis b surface antigens - biosynthesis |
4 |
|
hepatitis b surface antigens - genetics - immunology |
4 |
|
hepatitis b vaccines - administration & dosage |
4 |
|
hepatitis b vaccines - administration & dosage - immunology |
4 |
|
hepatitis b virus - immunology - metabolism |
4 |
|
herpes zoster |
4 |
|
herpes zoster - epidemiology - etiology - pathology |
4 |
|
herpesvirus 4, human - immunology |
4 |
|
hexosyltransferases |
4 |
|
histidine |
4 |
|
histopathology |
4 |
|
hiv core protein p24 - immunology |
4 |
|
hiv infections - prevention and control |
4 |
|
hiv-1 - immunology |
4 |
|
host susceptibilities |
4 |
|
hrv-c |
4 |
|
hsp70 heat-shock proteins - metabolism |
4 |
|
human hepegivirus 1 |
4 |
|
human herpesvirus 6 |
4 |
|
human infection |
4 |
|
humoral immune response |
4 |
|
hydrodynamic transfection |
4 |
|
hypervirulent strain |
4 |
|
ifn |
4 |
|
ifnar1 promoter polymorphisms |
4 |
|
immune impairment |
4 |
|
immunocompromised host - drug effects |
4 |
|
immunodeficiency |
4 |
|
immunogenic protein |
4 |
|
immunoglobulin a - immunology |
4 |
|
immunoglobulin g - biosynthesis - blood - immunology |
4 |
|
immunologic techniques |
4 |
|
immunosuppressive agents - adverse effects |
4 |
|
immunosuppressive agents - adverse effects - therapeutic use |
4 |
|
immunotherapy |
4 |
|
inactivated influenza |
4 |
|
inbred mouse lines |
4 |
|
infection control - standards |
4 |
|
infectious diarrhoea |
4 |
|
influenza (h7n9) virus |
4 |
|
influenza a virus - classification - genetics - pathogenicity |
4 |
|
influenza a virus - classification - isolation and purification |
4 |
|
influenza a virus, h1n1 subtype - drug effects |
4 |
|
influenza a virus, h1n1 subtype - genetics - physiology |
4 |
|
influenza a virus, h1n1 subtype - immunology - isolation and purification |
4 |
|
influenza a virus, h5n1 subtype - genetics - immunology - isolation & purification |
4 |
|
influenza a virus, h5n1 subtype - genetics - physiology |
4 |
|
influenza a virus, h5n1 subtype - isolation and purification |
4 |
|
influenza a virus, h7n9 subtype - immunology - isolation and purification |
4 |
|
influenza a virus, h7n9 subtype - isolation and purification |
4 |
|
influenza in birds - epidemiology - virology |
4 |
|
influenza in birds - transmission |
4 |
|
influenza, human - blood - pathology - virology |
4 |
|
influenza, human - epidemiology - prevention and control - transmission - virology |
4 |
|
influenza, human - pathology - physiopathology - virology |
4 |
|
inhibition of hbv transgene |
4 |
|
inhibition of scov reproduction |
4 |
|
innate immune response |
4 |
|
interferon type i - genetics - immunology |
4 |
|
interferon-alpha - metabolism |
4 |
|
interferon-gamma |
4 |
|
interferon-gamma - secretion |
4 |
|
interferon-α1 |
4 |
|
interleukin-4 - secretion |
4 |
|
intussusception - diagnosis - parasitology |
4 |
|
jaundice, obstructive - complications - diagnosis - microbiology |
4 |
|
jn.1 |
4 |
|
kidney - virology |
4 |
|
kidney calculi - epidemiology - metabolism - urine |
4 |
|
l336m |
4 |
|
lactobacillus |
4 |
|
lactobacillus rhamnosus |
4 |
|
lactobacillus rhamnosus - genetics - isolation & purification |
4 |
|
lhybrid camel |
4 |
|
lineage |
4 |
|
linkage disequilibrium |
4 |
|
liver - pathology |
4 |
|
liver - radiography |
4 |
|
liver abscess |
4 |
|
liver abscess - complications - diagnosis - microbiology |
4 |
|
liver cirrhosis, alcoholic - complications |
4 |
|
liver failure - complications |
4 |
|
liver transplantation |
4 |
|
lung - microbiology - pathology - radiography |
4 |
|
lung diseases, parasitic - diagnosis |
4 |
|
lymphocyte activation |
4 |
|
lymphoma - blood - complications - drug therapy - virology |
4 |
|
lymphoma, follicular - drug therapy - immunology |
4 |
|
lymphoma, non-hodgkin - drug therapy - immunology |
4 |
|
macaca mulatta |
4 |
|
macrolides - therapeutic use |
4 |
|
macrophage |
4 |
|
macrophages - metabolism - virology |
4 |
|
macrophages, peritoneal - immunology - transplantation - virology |
4 |
|
mating type genes |
4 |
|
maxillary sinusitis - complications - microbiology |
4 |
|
mdscs |
4 |
|
melamine |
4 |
|
melamine-associated renal stone disease |
4 |
|
melioidosis - diagnosis - genetics - microbiology |
4 |
|
membrane glycoproteins - analysis - blood - immunology |
4 |
|
membrane glycoproteins - chemistry |
4 |
|
membrane glycoproteins - chemistry - genetics - immunology |
4 |
|
membrane proteins - metabolism |
4 |
|
memory cd8 t cell response |
4 |
|
metagenomic analysis |
4 |
|
microscopy |
4 |
|
middle east respiratory syndrome coronavirus (mers-cov) |
4 |
|
mirizzi syndrome |
4 |
|
mirna-seq |
4 |
|
molecular biology |
4 |
|
molecular chaperones - metabolism |
4 |
|
molecular sequence numbers |
4 |
|
monitoring, physiologic - methods |
4 |
|
monkeys |
4 |
|
monocytes |
4 |
|
moraxellaceae - classification - cytology - isolation & purification - physiology |
4 |
|
moraxellaceae infections - complications - microbiology |
4 |
|
mouth mucosa |
4 |
|
movement |
4 |
|
mrna vaccine |
4 |
|
mrna-seq |
4 |
|
mucorales - isolation & purification - physiology |
4 |
|
mucormycosis - microbiology |
4 |
|
multidrug-resistant organisms |
4 |
|
multiple myeloma - complications - diagnosis - pathology - therapy |
4 |
|
multiple myeloma - therapy |
4 |
|
multiple organ failure - etiology |
4 |
|
multivalent vaccine |
4 |
|
muramoylpentapeptide carboxypeptidase - analysis |
4 |
|
mycobacteriosis |
4 |
|
mycobacterium tuberculosis - classification - genetics - metabolism - pathogenicity |
4 |
|
mycobacterium tuberculosis - drug effects - genetics |
4 |
|
mycobacterium tuberculosis - genetics |
4 |
|
mycoplasma pneumoniae - metabolism |
4 |
|
mycoses - complications - microbiology |
4 |
|
mycoses - epidemiology - microbiology |
4 |
|
mycoses - etiology - mortality |
4 |
|
mycoses - microbiology |
4 |
|
mycosis |
4 |
|
nasal colonisation |
4 |
|
nasopharyngeal carcinoma |
4 |
|
nasopharyngeal neoplasms - complications - therapy |
4 |
|
nasopharyngeal neoplasms - immunology - therapy - virology |
4 |
|
nasopharynx - microbiology |
4 |
|
neisseriaceae - classification - drug effects - isolation & purification |
4 |
|
neisseriaceae - classification - genetics - isolation & purification - pathogenicity |
4 |
|
neisseriaceae - classification - genetics - isolation & purification - ultrastructure |
4 |
|
neisseriaceae - drug effects - growth & development - isolation & purification |
4 |
|
neisseriaceae - growth & development - isolation & purification |
4 |
|
neisseriaceae - isolation and purification |
4 |
|
neisseriaceae infections - epidemiology - microbiology |
4 |
|
neuraminidase - antagonists & inhibitors - genetics |
4 |
|
neutropenia - complications |
4 |
|
neutropenia - microbiology |
4 |
|
new |
4 |
|
newly assigned functions |
4 |
|
newly found genes |
4 |
|
norovirus - classification - genetics - isolation and purification |
4 |
|
norovirus - genetics |
4 |
|
nose diseases - microbiology |
4 |
|
nosocomial |
4 |
|
novel bacterium |
4 |
|
novel coronaviruses |
4 |
|
novel picobirnaviruses |
4 |
|
nucleocapsid proteins - genetics - metabolism |
4 |
|
occupational exposure |
4 |
|
omicron breakthrough infection |
4 |
|
opportunistic infections - diagnosis - immunology - microbiology |
4 |
|
oral cavity |
4 |
|
oral mucositis |
4 |
|
orf1ab |
4 |
|
orf8 |
4 |
|
organ specificity |
4 |
|
orthomyxoviridae infections - virology |
4 |
|
oxidation-reduction |
4 |
|
pa |
4 |
|
palliative care - methods |
4 |
|
pancytopenia - blood - complications - drug therapy - virology |
4 |
|
papillomavirus infections - diagnosis - etiology - virology |
4 |
|
papillomavirus infections - etiology - pathology |
4 |
|
paracetamol |
4 |
|
parotid abscess |
4 |
|
parotid diseases - microbiology |
4 |
|
parotid gland - microbiology |
4 |
|
parotid neoplasms - complications - microbiology |
4 |
|
partitivirus |
4 |
|
patients |
4 |
|
penicillin-binding proteins |
4 |
|
penicillins - therapeutic use |
4 |
|
penicillium - classification - genetics - physiology |
4 |
|
penicillium - classification - immunology - isolation & purification |
4 |
|
penicillium - metabolism |
4 |
|
peptide elongation factor 1 - genetics |
4 |
|
peptides - chemistry - genetics |
4 |
|
peptidyl transferases |
4 |
|
peptococcaceae - classification - cytology - isolation & purification - physiology |
4 |
|
peripheral blood monocyte |
4 |
|
peritoneal dialysis, continuous ambulatory - adverse effects |
4 |
|
peritonitis - classification - etiology - microbiology |
4 |
|
peritonitis - drug therapy - etiology - microbiology |
4 |
|
peritonitis - microbiology |
4 |
|
persistent virus infection |
4 |
|
pge2 |
4 |
|
phosphoric monoester hydrolases - genetics |
4 |
|
picobirnavirus - genetics - isolation and purification |
4 |
|
picornavirus |
4 |
|
plasmid |
4 |
|
plasmid profile |
4 |
|
plasmids - metabolism |
4 |
|
plesiomonas - classification - isolation & purification |
4 |
|
plesiomonas shigelloides |
4 |
|
pneumococcal infections |
4 |
|
pneumococcal infections - complications - diagnosis - pathology - therapy |
4 |
|
pneumococcal infections/drug therapy |
4 |
|
pneumonia - complications - microbiology |
4 |
|
pneumonia - drug therapy - radiography |
4 |
|
point-of care |
4 |
|
polyoma bk virus |
4 |
|
polyomavirus infections - complications - diagnosis |
4 |
|
polyphyletic |
4 |
|
poultry workers |
4 |
|
practice guidelines as topic |
4 |
|
prevention of xbb.1.5 transmission |
4 |
|
proctitis - complications |
4 |
|
programmed cell death 1 receptor - immunology |
4 |
|
protease factor xa |
4 |
|
protease inhibitor |
4 |
|
protein binding |
4 |
|
protein conformation |
4 |
|
protein denaturation |
4 |
|
proteinase k |
4 |
|
proteomics |
4 |
|
proteus mirabilis - classification - drug effects - enzymology |
4 |
|
pseudobacteremia |
4 |
|
pulmonary delivery |
4 |
|
pulmonary eosinophilia - diagnosis - parasitology |
4 |
|
q fever |
4 |
|
q fever - diagnosis - epidemiology |
4 |
|
re-annotation |
4 |
|
reactive dermatosis |
4 |
|
realstar® hhv-6 pcr kit |
4 |
|
reassortant viruses - immunology - isolation and purification |
4 |
|
recombinant proteins - immunology - isolation & purification |
4 |
|
recombinases - genetics |
4 |
|
recombineering salmonella vaccine |
4 |
|
rectal neoplasms - complications |
4 |
|
rectum - microbiology |
4 |
|
replication origin - genetics |
4 |
|
resequencing microarray |
4 |
|
reservoir |
4 |
|
respiratory tracts |
4 |
|
reverse transcriptase polymerase chain reaction - methods - statistics & numerical |
4 |
|
rna virus infections - epidemiology - transmission - virology |
4 |
|
rna virus infections - veterinary - virology |
4 |
|
rna viruses - genetics - growth & development |
4 |
|
rna, small interfering |
4 |
|
rna, small interfering - genetics |
4 |
|
rna,-bacterial-genetics |
4 |
|
rna,-ribosomal,-16s-analysis |
4 |
|
rodentia - microbiology |
4 |
|
saliva - microbiology |
4 |
|
salmonella typhi - classification - genetics - isolation & purification |
4 |
|
salmonella typhi - genetics - metabolism |
4 |
|
sampling studies |
4 |
|
sars virus - enzymology - genetics - pathogenicity - physiology |
4 |
|
sars virus - immunology - isolation & purification |
4 |
|
sars-associated coronavirus |
4 |
|
sea lions - virology |
4 |
|
seafood - microbiology |
4 |
|
seasonal |
4 |
|
sedimentibacter hongkongensis sp. nov. |
4 |
|
sequence |
4 |
|
serological surveillance |
4 |
|
severe acute respiratory syndrome - diagnosis - epidemiology |
4 |
|
severe acute respiratory syndrome - drug therapy - physiopathology - virology |
4 |
|
severe acute respiratory syndrome coronavirus (sars-cov) |
4 |
|
severe acute respiratory syndrome coronavirus 2 |
4 |
|
sexual cycle |
4 |
|
sirna |
4 |
|
skin diseases - diagnosis - microbiology |
4 |
|
skin diseases - microbiology - therapy |
4 |
|
specific pathogen-free organisms |
4 |
|
staphylococcal infections - diagnosis - etiology - microbiology |
4 |
|
staphylococcal-infections-microbiology |
4 |
|
staphylococcus - drug effects |
4 |
|
staphylococcus aureus - drug effects - isolation & purification - ultrastructure |
4 |
|
staphylococcus aureus - isolation & purification |
4 |
|
staphylococcus-classification |
4 |
|
stem cell transplantation - adverse effects |
4 |
|
stomatitis - drug therapy - prevention & control |
4 |
|
streptococcal infections - epidemiology |
4 |
|
streptococcal infections - etiology |
4 |
|
streptococcus - classification - genetics |
4 |
|
streptococcus - genetics - isolation & purification |
4 |
|
streptococcus anginosus |
4 |
|
streptococcus anginosus - genetics - isolation & purification |
4 |
|
streptococcus bovis - classification - genetics |
4 |
|
streptococcus milleri |
4 |
|
streptococcus pneumoniae - drug effects |
4 |
|
streptococcus pneumoniae/drug effects |
4 |
|
streptococcus sinensis |
4 |
|
structural fitness of antibody |
4 |
|
subcutaneous tissue |
4 |
|
substance abuse, intravenous - complications |
4 |
|
sweet's syndrome |
4 |
|
switzerland - epidemiology |
4 |
|
synteny |
4 |
|
t cell exhaustion |
4 |
|
t cell immunity |
4 |
|
t cell-mediated response |
4 |
|
teicoplanin - therapeutic use |
4 |
|
temporal dynamics |
4 |
|
tenericutes - classification - isolation & purification |
4 |
|
th1 cells - immunology |
4 |
|
th1 cells - immunology - secretion |
4 |
|
the neisseriaceae family |
4 |
|
therapeutic irrigation - methods |
4 |
|
therapeutics |
4 |
|
tickborne diseases |
4 |
|
tissue |
4 |
|
tissue tropism |
4 |
|
toxin a (tcda) |
4 |
|
toxin b (tcdb) |
4 |
|
trans-activators - genetics |
4 |
|
transaminases - genetics |
4 |
|
transcriptional activity |
4 |
|
transformation |
4 |
|
transgenes |
4 |
|
transplantation |
4 |
|
transplantation conditioning - adverse effects - methods |
4 |
|
transplantation immunology |
4 |
|
traveller's diarrhoea |
4 |
|
triazines - administration & dosage - metabolism - urine |
4 |
|
trichuriasis - complications |
4 |
|
trichuris - isolation and purification |
4 |
|
tuberculin test |
4 |
|
tuberculosis - diagnosis - microbiology |
4 |
|
tuberculosis, lymph node - diagnosis - drug therapy |
4 |
|
tuberculosis, meningeal - microbiology |
4 |
|
tuberculosis, miliary - diagnosis - drug therapy |
4 |
|
tuberculosis, multidrug-resistant - diagnosis - microbiology |
4 |
|
tuberculosis, pulmonary - diagnosis - microbiology |
4 |
|
tuberculosis, pulmonary - drug therapy - etiology - immunology - physiopathology - |
4 |
|
tumor cells, cultured |
4 |
|
tumor virus infections - etiology - pathology |
4 |
|
typhoid fever - microbiology |
4 |
|
united arab emirates |
4 |
|
up-regulation |
4 |
|
urinary bladder - metabolism - pathology |
4 |
|
urinary tract infections - diagnosis - urine - virology |
4 |
|
uterine cervical neoplasms - complications - radiotherapy |
4 |
|
vaccines, dna - immunology |
4 |
|
vaccines, synthetic - immunology |
4 |
|
vancomycin - therapeutic use |
4 |
|
varicella zoster virus |
4 |
|
varicella-zoster virus |
4 |
|
veillonellaceae |
4 |
|
vero cells |
4 |
|
verocytotoxigenic escherichia coli |
4 |
|
vidarabine - adverse effects - analogs & derivatives |
4 |
|
viral envelope proteins - chemistry |
4 |
|
viral kinetics |
4 |
|
viral matrix proteins - immunology - metabolism |
4 |
|
viral proteins - chemistry - genetics - metabolism |
4 |
|
viral vaccines - immunology |
4 |
|
virology - methods |
4 |
|
virology - methods - standards |
4 |
|
virus activation |
4 |
|
virus activation - drug effects |
4 |
|
virus activation - physiology |
4 |
|
virus assembly |
4 |
|
virus replication - immunology |
4 |
|
vps34 |
4 |
|
wolbachia |
4 |
|
world health |
4 |
|
zoonoses - epidemiology - transmission - virology |
4 |
|
β-lactams |
4 |
|
γδ t cell |
4 |
|
16s rrna gene sequencing |
3 |
|
2-propanol - pharmacology |
3 |
|
acinetobacter - drug effects - genetics - isolation and purification |
3 |
|
acinetobacter baumannii |
3 |
|
acinetobacter infections - epidemiology |
3 |
|
actinobacteria - classification - genetics - isolation & purification |
3 |
|
actinobacteria - genetics |
3 |
|
actinomyces - classification - genetics - isolation & purification |
3 |
|
actinomycetales - classification - genetics - isolation & purification |
3 |
|
actinomycetales - classification - genetics - isolation & purification - pathogenicity |
3 |
|
actinomycetales infections - etiology - microbiology |
3 |
|
actinomycosis - diagnosis - microbiology |
3 |
|
acupuncture analgesia - adverse effects |
3 |
|
acute cholangitis |
3 |
|
acute disseminated encephalomyelitis |
3 |
|
acute kidney injury |
3 |
|
acyltransferases - genetics - metabolism - toxicity |
3 |
|
adeno-associated viral vector |
3 |
|
adenoviridae - genetics |
3 |
|
adenoviruses, human - isolation & purification |
3 |
|
administration, intranasal |
3 |
|
administration, topical |
3 |
|
adult croup |
3 |
|
adverse effect |
3 |
|
aedes |
3 |
|
agar |
3 |
|
age distribution |
3 |
|
aids-related opportunistic infections - epidemiology - microbiology |
3 |
|
aids-related opportunistic infections - microbiology |
3 |
|
air |
3 |
|
airborne |
3 |
|
albendazole |
3 |
|
alcohol hand rub |
3 |
|
alcohols - therapeutic use |
3 |
|
allergens |
3 |
|
allogeneic |
3 |
|
amino acid deletion |
3 |
|
amino terminal sequence |
3 |
|
amoxicillin - administration & dosage - therapeutic use |
3 |
|
amoxicillin-potassium clavulanate combination |
3 |
|
amphotericin b - administration & dosage |
3 |
|
amphotericin b - therapeutic use |
3 |
|
ampicillin |
3 |
|
ampicillin - pharmacology |
3 |
|
ampicillin resistance |
3 |
|
amplityping |
3 |
|
analysis of variance |
3 |
|
androstadienes - administration & dosage - therapeutic use |
3 |
|
animal rna virus |
3 |
|
anti-aquaporin-4 antibody |
3 |
|
anti-bacterial agents - administration & dosage |
3 |
|
anti-bacterial agents - analysis - biosynthesis |
3 |
|
anti-bacterial agents - immunology - pharmacology |
3 |
|
anti-bacterial agents - metabolism - pharmacology |
3 |
|
anti-hiv agents - pharmacology |
3 |
|
anti-inflammatory agents - administration & dosage - therapeutic use |
3 |
|
antibiotic control |
3 |
|
antibiotics, antitubercular - pharmacology |
3 |
|
antibodies, bacterial - biosynthesis - immunology |
3 |
|
antibodies, bacterial - blood |
3 |
|
antibodies, viral - immunology |
3 |
|
antibody formation - drug effects |
3 |
|
antibody formation - immunology |
3 |
|
antifungal |
3 |
|
antifungal prescription |
3 |
|
antigen-antibody complex - immunology |
3 |
|
antigens, bacterial - immunology |
3 |
|
antigens, fungal - chemistry - genetics - immunology |
3 |
|
antineoplastic agents, alkylating - toxicity |
3 |
|
antiporters - genetics |
3 |
|
antiretroviral therapy, highly active |
3 |
|
antiretroviral therapy, highly active - classification - methods |
3 |
|
aortic aneurysm, abdominal - microbiology |
3 |
|
appendicitis - complications - microbiology |
3 |
|
appendicitis - etiology |
3 |
|
arthritis, infectious - drug therapy - etiology - microbiology |
3 |
|
ascomycota |
3 |
|
ascomycota - genetics |
3 |
|
asia, southeastern - epidemiology |
3 |
|
aspergillosis - complications - drug therapy |
3 |
|
aspergillosis - diagnosis |
3 |
|
aspergillosis - diagnosis - drug therapy - etiology |
3 |
|
aspergillosis - immunology - microbiology |
3 |
|
aspergillus - drug effects - growth & development |
3 |
|
aspergillus fumigatus - classification - genetics |
3 |
|
aspergillus fumigatus - genetics - immunology - ultrastructure |
3 |
|
aspergillus fumigatus - immunology |
3 |
|
asthma |
3 |
|
atp-binding cassette transporters |
3 |
|
autophagy |
3 |
|
autophagy - immunology |
3 |
|
avian influenza a h9n2 |
3 |
|
avian influenza h7n9 |
3 |
|
bacteremia - complications - drug therapy - epidemiology |
3 |
|
bacteremia - complications - drug therapy - microbiology |
3 |
|
bacteremia - diagnosis - drug therapy - epidemiology |
3 |
|
bacteremia - diagnosis - epidemiology - microbiology |
3 |
|
bacteremia - etiology - microbiology |
3 |
|
bacteremia-microbiology |
3 |
|
bacteria - classification - genetics - isolation & purification - metabolism |
3 |
|
bacteria - drug effects |
3 |
|
bacteria - pathogenicity |
3 |
|
bacteria, anaerobic - classification - isolation & purification |
3 |
|
bacteria,-anaerobic-classification |
3 |
|
bacterial gene |
3 |
|
bacterial infections |
3 |
|
bacterial strain |
3 |
|
bacterial toxins - genetics - metabolism - toxicity |
3 |
|
bacterial typing techniquesy |
3 |
|
bacterial vaccines - immunology |
3 |
|
bacterial-toxins-biosynthesis |
3 |
|
bacterial-typing-techniques-methods |
3 |
|
bacterium examination |
3 |
|
bacterium identification |
3 |
|
bacterium isolation |
3 |
|
bacteriuria - epidemiology - microbiology |
3 |
|
bangladesh |
3 |
|
beauty |
3 |
|
benzoates - therapeutic use |
3 |
|
beta-lactam resistance - genetics |
3 |
|
beta-lactamases - analysis - antagonists & inhibitors |
3 |
|
beta-lactamases - genetics |
3 |
|
biliary tract disease |
3 |
|
biliary tract diseases - complications |
3 |
|
bioinformatics |
3 |
|
biological evolution |
3 |
|
bk virus |
3 |
|
bk virus - genetics - isolation & purification - physiology |
3 |
|
bkv |
3 |
|
blood transfusion - adverse effects |
3 |
|
bloodstream isolates |
3 |
|
breast milk |
3 |
|
bronchiectasis - drug therapy - immunology - microbiology - pathology |
3 |
|
bronchoalveolar lavage fluid - virology |
3 |
|
bronchoscopy |
3 |
|
burkholderia - classification - genetics - isolation and purification |
3 |
|
burkholderia infections - diagnosis - microbiology |
3 |
|
burkholderia pseudomallei - chemistry - classification - genetics |
3 |
|
burkholderia pseudomallei - classification - genetics - isolation & purification |
3 |
|
burkholderia pseudomallei - drug effects |
3 |
|
burkholderia pseudomallei - enzymology - genetics - isolation & purification |
3 |
|
burkholderia pseudomallei - genetics - immunology |
3 |
|
ca-mrsa |
3 |
|
campylobacter infections - diagnosis - drug therapy - epidemiology |
3 |
|
campylobacter jejuni - drug effects - isolation & purification |
3 |
|
candida - isolation & purification |
3 |
|
candida - pathogenicity |
3 |
|
candida albicans - pathogenicity |
3 |
|
candidiasis - complications - microbiology |
3 |
|
candidiasis, oral - microbiology |
3 |
|
carbapenemase |
3 |
|
carrier proteins - chemistry - genetics - immunology - metabolism |
3 |
|
carrier state - epidemiology - microbiology |
3 |
|
carrier state - virology |
3 |
|
cat diseases |
3 |
|
catalase - genetics |
3 |
|
catheters, indwelling - microbiology |
3 |
|
ccr5 polymorphism |
3 |
|
cd4-positive t-lymphocytes - immunology |
3 |
|
cd8-positive t-lymphocytes - immunology |
3 |
|
cefotaxime - therapeutic use |
3 |
|
ceftazidime - metabolism |
3 |
|
ceftriaxone - therapeutic use |
3 |
|
cell adhesion |
3 |
|
cell lineage - genetics |
3 |
|
cell wall |
3 |
|
cell wall - physiology |
3 |
|
celllulitis |
3 |
|
cellulitis - diagnosis - microbiology |
3 |
|
cellulitis - drug therapy - etiology - microbiology |
3 |
|
cestodes |
3 |
|
chemokine ccl5 - blood - genetics |
3 |
|
chemokine cxcl10 - biosynthesis |
3 |
|
chickenpox vaccine - administration & dosage |
3 |
|
chimney effect |
3 |
|
china - ethnology |
3 |
|
chinese wet-market |
3 |
|
cholangitis - complications |
3 |
|
cholera - complications - microbiology |
3 |
|
cholera toxin - genetics |
3 |
|
chromatography, high pressure liquid |
3 |
|
chronic graft versus host disease |
3 |
|
cilia |
3 |
|
cladribine - adverse effects |
3 |
|
clarithromycin - administration & dosage - therapeutic use |
3 |
|
clarithromycin - immunology - pharmacology |
3 |
|
clavulanic acid - administration & dosage - therapeutic use |
3 |
|
clinical article |
3 |
|
clostridium - classification - genetics - isolation & purification |
3 |
|
clostridium - classification - isolation & purification - pathogenicity |
3 |
|
clostridium difficile - drug effects - growth & development |
3 |
|
clostridium infections - diagnosis - epidemiology - microbiology |
3 |
|
co-trimoxazole |
3 |
|
codon usage bias |
3 |
|
colitis - microbiology - pathology |
3 |
|
combination antiretroviral therapy |
3 |
|
combinational therapy |
3 |
|
communicable diseases, emerging - prevention & control - transmission |
3 |
|
community-acquired infections - diagnosis - epidemiology - virology |
3 |
|
community-acquired legionellosis |
3 |
|
comparative genomic hybridization |
3 |
|
conjunctivitis, bacterial - diagnosis - microbiology |
3 |
|
cord blood transplant |
3 |
|
coreceptor function |
3 |
|
coronaviridae - classification - genetics |
3 |
|
coronavirus - isolation & purification |
3 |
|
coronavirus infections - diagnosis - epidemiology - virology |
3 |
|
cox1 gene |
3 |
|
cpg islands |
3 |
|
cpg suppression |
3 |
|
crf01_ae |
3 |
|
cross infection - diagnosis |
3 |
|
cross infection - epidemiology - prevention & control |
3 |
|
croup |
3 |
|
croup - diagnosis - therapy - virology |
3 |
|
cxcl10 |
3 |
|
cyclophosphamide |
3 |
|
cyclophosphamide - toxicity |
3 |
|
cysteine endopeptidases |
3 |
|
cystitis - epidemiology - microbiology |
3 |
|
cystitis - etiology - prevention & control - virology |
3 |
|
cystitis - etiology - urine |
3 |
|
cytokine-induced killer cell therapy |
3 |
|
cytokines - biosynthesis |
3 |
|
cytokines - biosynthesis - genetics - secretion |
3 |
|
cytomegalovirus infections - virology |
3 |
|
cytosine - chemistry |
3 |
|
cytosine deamination |
3 |
|
cytotoxins-biosynthesis |
3 |
|
d614g |
3 |
|
databases, genetic |
3 |
|
dependovirus - genetics |
3 |
|
dependovirus - genetics - immunology |
3 |
|
dependovirus - genetics - metabolism |
3 |
|
dermatophyte |
3 |
|
diagnostic test |
3 |
|
dialysis solutions |
3 |
|
diarrhea-microbiology |
3 |
|
directly observed hand hygiene |
3 |
|
directly observed therapy - methods |
3 |
|
disease reservoirs - microbiology |
3 |
|
disease transmission, infectious |
3 |
|
disinfectants - pharmacology |
3 |
|
dna technology |
3 |
|
dna transposable elements - genetics |
3 |
|
dna, fungal - genetics - isolation & purification |
3 |
|
dna, recombinant - genetics |
3 |
|
dna, recombinant - immunology |
3 |
|
dna,-bacterial-genetics |
3 |
|
dna-directed rna polymerases - chemistry - genetics |
3 |
|
dose optimization |
3 |
|
dose-response relationship, drug |
3 |
|
drainage system |
3 |
|
drinking water |
3 |
|
droplet |
3 |
|
drug contamination |
3 |
|
drug resistance |
3 |
|
drug resistance, microbial - genetics |
3 |
|
drug resistance, multiple |
3 |
|
early clinical diagnosis |
3 |
|
ebola virus disease |
3 |
|
ebolavirus |
3 |
|
eggerthella bactermia |
3 |
|
elbow |
3 |
|
electronics - instrumentation - methods - organization and administration |
3 |
|
encephalitis, herpes simplex - complications - immunology |
3 |
|
encephalomyelitis, acute disseminated - diagnosis - etiology - virology |
3 |
|
endocarditis - drug therapy - etiology - microbiology |
3 |
|
endopeptidases - metabolism |
3 |
|
enterobacteriaceae - drug effects - genetics |
3 |
|
enterobacteriaceae infections - diagnosis - drug therapy - microbiology |
3 |
|
enterobacteriaceae infections - epidemiology - metabolism |
3 |
|
enterococcus - classification - drug effects - isolation & purification |
3 |
|
enterococcus faecium - growth & development - pathogenicity |
3 |
|
enterocolitis, pseudomembranous - microbiology |
3 |
|
environmental hygiene |
3 |
|
enzyme inhibitors - pharmacology |
3 |
|
epidemic |
3 |
|
epithelial cells |
3 |
|
epithelium - microbiology |
3 |
|
epitopes - immunology |
3 |
|
equipment contamination |
3 |
|
erythema nodosum |
3 |
|
erythromycin |
3 |
|
escherichia coli - classification - genetics - isolation and purification |
3 |
|
escherichia coli - drug effects - enzymology |
3 |
|
escherichia coli - drug effects - genetics |
3 |
|
escherichia coli - enzymology - genetics |
3 |
|
escherichia coli - growth & development - isolation & purification |
3 |
|
escherichia coli infections - complications - diagnosis - epidemiology - microbiology |
3 |
|
escherichia coli infections - epidemiology - microbiology |
3 |
|
escherichia coli proteins - genetics |
3 |
|
escherichia coli proteins - immunology |
3 |
|
escherichia-coli-infections-microbiology |
3 |
|
escherichia-coli-o157-metabolism |
3 |
|
evolutionary rate |
3 |
|
exanthema - diagnosis - microbiology |
3 |
|
exophiala - drug effects - isolation & purification |
3 |
|
expression and conformation |
3 |
|
extended-spectrum beta-lactamase |
3 |
|
facility design and construction |
3 |
|
false negative reactions |
3 |
|
fatal infection |
3 |
|
fecal aerosol |
3 |
|
fetal blood - microbiology |
3 |
|
fever of unknown origin - etiology |
3 |
|
flagellin - genetics |
3 |
|
fluorescent antibody technique, direct |
3 |
|
fluorogenic substrate |
3 |
|
forecasting |
3 |
|
fungal proteins - analysis - genetics - immunology - metabolism |
3 |
|
fungal proteins - chemistry - genetics - immunology |
3 |
|
fungal proteins - immunology |
3 |
|
fungal structures - cytology |
3 |
|
fungemia - complications - microbiology |
3 |
|
fungemia - diagnosis - microbiology |
3 |
|
fungi - cytology |
3 |
|
galactose - metabolism - pharmacology |
3 |
|
ganciclovir |
3 |
|
gas chromatography-mass spectrometry |
3 |
|
gastroenteritis - genetics - microbiology |
3 |
|
gastrointestinal tract - chemistry - virology |
3 |
|
gene expression regulation, bacterial - immunology |
3 |
|
gene expression regulation, viral - drug effects |
3 |
|
gene transfer, horizontal |
3 |
|
genes, viral |
3 |
|
genetic complementation test |
3 |
|
genetic drift |
3 |
|
genetic speciation |
3 |
|
genetic techniques |
3 |
|
genomic analysis |
3 |
|
genotyping resistance test |
3 |
|
gentamicins - administration & dosage - therapeutic use |
3 |
|
glucocorticoids - therapeutic use |
3 |
|
graft vs host disease - virology |
3 |
|
gram-negative aerobic rods and cocci - isolation & purification |
3 |
|
gram-negative bacteria - cytology - isolation & purification |
3 |
|
gram-negative bacterial infections - complications - drug therapy - epidemiology - microbiology |
3 |
|
gram-positive bacteria - classification - genetics - isolation & purification |
3 |
|
gram-positive bacteria - cytology - isolation & purification |
3 |
|
gram-positive bacterial infections - diagnosis - epidemiology - microbiology |
3 |
|
gram-positive bacterial infections - epidemiology - microbiology |
3 |
|
gram-positive bacterial infections - epidemiology - prevention & control |
3 |
|
gram-positive bacterial infections - genetics |
3 |
|
gram-positive cocci - drug effects - genetics |
3 |
|
gram-positive-bacteria-classification |
3 |
|
gram-positive-bacterial-infections-diagnosis |
3 |
|
gram-positive-bacterial-infections-microbiology |
3 |
|
granulomatous disease, chronic - immunology |
3 |
|
groel protein - genetics |
3 |
|
guideline adherence - organization and administration |
3 |
|
h1n1 subtype |
3 |
|
h275y |
3 |
|
haematopoietic stem cell transplantation |
3 |
|
haemophilus - classification - genetics - growth & development |
3 |
|
haemophilus infections - microbiology |
3 |
|
hafnia alvei - classification - isolation & purification |
3 |
|
handwashing - standards |
3 |
|
hematopoietic stem cell transplantation - methods |
3 |
|
hematuria - etiology - virology |
3 |
|
hepatitis antibodies |
3 |
|
hepatitis b antibodies - immunology |
3 |
|
hepatitis b e antigens - blood - genetics |
3 |
|
hepatitis b surface antigens - blood - genetics |
3 |
|
hepatitis b surface antigens - blood - immunology |
3 |
|
hepatitis b vaccines - immunology |
3 |
|
hepatitis b vaccines - therapeutic use |
3 |
|
hepatitis b virus - drug effects - genetics - physiology |
3 |
|
hepatitis e virus |
3 |
|
herpes simplex - diagnosis - drug therapy - etiology |
3 |
|
herpes zoster - prevention & control |
3 |
|
heterozygote |
3 |
|
histiocytosis, non-langerhans-cell - microbiology - pathology |
3 |
|
hiv - metabolism |
3 |
|
hiv infection |
3 |
|
hiv infections - drug therapy - virology |
3 |
|
hiv infections - epidemiology - transmission |
3 |
|
hiv infections - genetics |
3 |
|
hiv infections - genetics - metabolism |
3 |
|
hiv-1 - classification - drug effects - genetics |
3 |
|
hiv-1 - classification - drug effects - genetics - isolation & purification |
3 |
|
hiv-1 - classification - genetics - physiology |
3 |
|
hiv-1 - genetics |
3 |
|
homozygote |
3 |
|
housing |
3 |
|
hpai |
3 |
|
human betacoronavirus 2c emc/2012 |
3 |
|
human metapneumovirus |
3 |
|
humanized mouse |
3 |
|
hydrolysis |
3 |
|
hygiene - standards |
3 |
|
hyperbilirubinemia - complications - microbiology - therapy |
3 |
|
immune |
3 |
|
immune responses |
3 |
|
immunity, active |
3 |
|
immunity, cellular - immunology |
3 |
|
immunity, natural |
3 |
|
immuno-reconstitution |
3 |
|
immunocompromised |
3 |
|
immunoenzyme techniques |
3 |
|
immunoglobulin g - analysis - biosynthesis |
3 |
|
in-house |
3 |
|
infection - transmission |
3 |
|
infection control - instrumentation - methods - organization and administration - standards |
3 |
|
infection control measure |
3 |
|
infectious disease transmission, patient-to-professional - prevention & control |
3 |
|
infectious mononucleosis - physiopathology - virology |
3 |
|
inflammation - drug therapy - etiology |
3 |
|
inflammation - prevention & control |
3 |
|
influenza a virus - immunology |
3 |
|
influenza a virus, h1n1 subtype - drug effects - genetics - immunology |
3 |
|
influenza a virus, h9n2 subtype - classification - genetics - isolation and purification |
3 |
|
influenza b |
3 |
|
influenza, human - complications - diagnosis - pathology - virology |
3 |
|
influenza, human - diagnosis - epidemiology - transmission - virology |
3 |
|
influenza, human - epidemiology - immunology - prevention and control - therapy |
3 |
|
influenza, human - immunology - virology |
3 |
|
influenza, human - prevention & control - transmission |
3 |
|
inh resistance |
3 |
|
inhibitory concentration 50 |
3 |
|
insertion sequence |
3 |
|
integrin 4β7 |
3 |
|
interferon-alpha - biosynthesis |
3 |
|
interferon-gamma - biosynthesis |
3 |
|
interleukin-4 - biosynthesis |
3 |
|
internet |
3 |
|
intestinal mucosa - drug effects |
3 |
|
intrauterine devices - microbiology |
3 |
|
is6110 |
3 |
|
isbp1 |
3 |
|
iterferon gamma |
3 |
|
ivig |
3 |
|
jaundice - complications - microbiology - therapy |
3 |
|
jc virus - isolation & purification |
3 |
|
katg |
3 |
|
keratinolytic |
3 |
|
kidney failure, acute - microbiology |
3 |
|
kidney failure, chronic - diagnosis - therapy |
3 |
|
kidney failure, chronic - therapy |
3 |
|
klebsiella infections - complications - diagnosis - drug therapy |
3 |
|
klebsiella pneumoniae - drug effects - enzymology |
3 |
|
klebsiella pneumoniae - drug effects - isolation & purification |
3 |
|
knee - microbiology - pathology |
3 |
|
lactobacillus - classification - genetics - isolation & purification |
3 |
|
lactobacillus fermentum |
3 |
|
leukemia - therapy |
3 |
|
leukemia, myelogenous, chronic, bcr-abl positive - complications - therapy |
3 |
|
leukemia, myeloid - complications - therapy |
3 |
|
leukemia, myeloid, acute - complications - therapy |
3 |
|
lineage specificity |
3 |
|
linear models |
3 |
|
lipopolysaccharides - immunology |
3 |
|
live attenuated s. typhimurium vaccine |
3 |
|
live-attenuated salmonella |
3 |
|
long-term care |
3 |
|
long-term care facilities |
3 |
|
lopinavir‐ritonavir |
3 |
|
lung diseases, fungal - diagnosis - drug therapy - etiology |
3 |
|
lung diseases, fungal - immunology - microbiology |
3 |
|
lupus erythematosus, systemic - complications |
3 |
|
lymphedema - complications |
3 |
|
maba-inha |
3 |
|
macrophages - immunology - microbiology - secretion |
3 |
|
macrophages - microbiology |
3 |
|
main protease |
3 |
|
maltose-binding proteins |
3 |
|
management |
3 |
|
mastectomy - adverse effects |
3 |
|
melanin |
3 |
|
melanins - biosynthesis |
3 |
|
melioidosis - diagnosis |
3 |
|
melioidosis - diagnosis - microbiology |
3 |
|
membrane glycoproteins - administration & dosage - immunology |
3 |
|
membrane glycoproteins - administration and dosage - genetics - immunology |
3 |
|
membrane glycoproteins - analysis - genetics - immunology - metabolism |
3 |
|
mental disorders |
3 |
|
metapneumovirus - classification - pathogenicity |
3 |
|
metapneumovirus - pathogenicity |
3 |
|
methicillin resistance - genetics |
3 |
|
methylmethacrylates - metabolism |
3 |
|
metronidazole - pharmacology |
3 |
|
mice, inbred balb/c |
3 |
|
microarray |
3 |
|
microbial viability - drug effects |
3 |
|
microbiology medical sciences |
3 |
|
microscopy - methods |
3 |
|
microscopy, immunoelectron |
3 |
|
middle east respiratory syndrome |
3 |
|
mlst |
3 |
|
models, biological |
3 |
|
models, theoretical |
3 |
|
molecular diagnosis |
3 |
|
monosaccharide transport proteins |
3 |
|
monte carlo method |
3 |
|
mouth mucosa - cytology - microbiology |
3 |
|
mouth mucosa - metabolism |
3 |
|
mp1p enzyme immunoassay |
3 |
|
mucositis |
3 |
|
multidrug-resistant |
3 |
|
multilocus sequence typing - methods |
3 |
|
multiple myeloma - complications - diagnosis |
3 |
|
multiple myeloma - complications - immunology |
3 |
|
multiplex allele-specific pcr |
3 |
|
multiplex pcr |
3 |
|
mycobacterial rna polymerase |
3 |
|
mycobacterium |
3 |
|
mycobacterium - classification - genetics - isolation & purification |
3 |
|
mycobacterium abscessus |
3 |
|
mycobacterium avium complex - chemistry - classification - genetics - isolation & purification |
3 |
|
mycobacterium avium-intracellulare infection - diagnosis |
3 |
|
mycobacterium chelonae - drug effects |
3 |
|
mycobacterium haemophilum - genetics - isolation and purification |
3 |
|
mycobacterium infections - diagnosis - drug therapy - microbiology - pathology |
3 |
|
mycobacterium infections - diagnosis - microbiology |
3 |
|
mycobacterium marinum - genetics - isolation and purification |
3 |
|
mycobacterium marinum - genetics - metabolism - pathogenicity |
3 |
|
mycobacterium smegmatis |
3 |
|
mycobacterium smegmatis - genetics |
3 |
|
mycobacterium smegmatis - genetics - metabolism - pathogenicity |
3 |
|
mycobacterium tuberculosis - chemistry - classification - genetics - isolation & purification |
3 |
|
mycobacterium tuberculosis - drug effects - isolation & purification |
3 |
|
mycobacterium tuberculosis - genetics - growth and development - isolation and purification - pathogenicity |
3 |
|
mycobacterium tuberculosis - genetics - immunology - isolation & purification - pathogenicity |
3 |
|
mycological typing techniques |
3 |
|
mycology - methods |
3 |
|
mycoses - blood - diagnosis - microbiology |
3 |
|
mycoses - complications - microbiology - pathology |
3 |
|
mycoses - diagnosis - drug therapy |
3 |
|
mycoses - diagnosis - drug therapy - immunology - microbiology |
3 |
|
mycoses - mortality |
3 |
|
myeloablative agonists - adverse effects |
3 |
|
n-terminal domain |
3 |
|
nematodes |
3 |
|
neoplasms - complications |
3 |
|
neuraminidase |
3 |
|
neuraminidase - genetics - immunology - metabolism |
3 |
|
neuromyelitis optica |
3 |
|
nosocomial legionellosis |
3 |
|
nuclear localization signal |
3 |
|
nucleic acid hybridization |
3 |
|
opportunistic infections - diagnosis - drug therapy - etiology |
3 |
|
opportunistic infections - etiology - virology |
3 |
|
opportunistic infections - microbiology |
3 |
|
orf3a |
3 |
|
orf3b |
3 |
|
orthomyxoviridae infections - immunology |
3 |
|
oxidoreductases - genetics |
3 |
|
pancytopenia |
3 |
|
pandemics |
3 |
|
para-influenza virus |
3 |
|
parainfluenza virus 3, human |
3 |
|
parainfluenza virus 3, human - isolation & purification |
3 |
|
parainfluenza virus type 3 |
3 |
|
paramyxoviridae - genetics - isolation and purification |
3 |
|
paramyxoviridae infections - chemically induced - complications |
3 |
|
paramyxoviridae infections - diagnosis - epidemiology - veterinary - virology |
3 |
|
paramyxoviridae infections - physiopathology - virology |
3 |
|
paramyxoviridae infections - prevention & control |
3 |
|
paramyxovirinae - genetics - isolation and purification |
3 |
|
penicillins - pharmacology |
3 |
|
penicilliosis |
3 |
|
penicillium - classification - drug effects - growth & development - metabolism |
3 |
|
penicillium - classification - genetics - isolation & purification |
3 |
|
penicillium - classification - genetics - pathogenicity - physiology |
3 |
|
penicillium - classification - isolation & purification |
3 |
|
penicillium - drug effects - genetics - pathogenicity - radiation effects |
3 |
|
penicillium - genetics - growth and development - pathogenicity |
3 |
|
peptides to t cell epitopes |
3 |
|
periplasmic binding proteins |
3 |
|
peritoneal dialysis |
3 |
|
peritonitis |
3 |
|
peritonitis - diagnosis - drug therapy - etiology |
3 |
|
peritonitis - drug therapy - microbiology |
3 |
|
phagocytes - physiology |
3 |
|
plasma exchange |
3 |
|
plasmapheresis |
3 |
|
plesiomonas - isolation & purification |
3 |
|
pneumocystis - immunology |
3 |
|
pneumonia, viral - diagnosis - drug therapy - etiology |
3 |
|
pneumonia, viral - diagnosis - epidemiology - virology |
3 |
|
point mutation - genetics |
3 |
|
polyketide synthase |
3 |
|
polyketide synthases - genetics |
3 |
|
polymorphism, genetic - genetics |
3 |
|
polyomavirus infections - complications - urine - virology |
3 |
|
polyomavirus infections - drug therapy - etiology |
3 |
|
polyomavirus infections - drug therapy - virology |
3 |
|
polyomavirus infections - etiology |
3 |
|
polyomavirus infections - immunology - urine - virology |
3 |
|
postoperative complications - drug therapy - etiology |
3 |
|
postoperative complications - microbiology |
3 |
|
prednisolone - therapeutic use |
3 |
|
pregnanc - complications, infectious - diagnosis - drug therapy |
3 |
|
pregnancy outcome |
3 |
|
preservation, biological - methods |
3 |
|
proactive infection control |
3 |
|
pseudomonas aeruginosa |
3 |
|
psychiatric department, hospital |
3 |
|
pulsed-field gel electrophoresis |
3 |
|
q57h |
3 |
|
quaternary epitope |
3 |
|
quinolones - pharmacology |
3 |
|
ralstonia pickettii |
3 |
|
random allocation |
3 |
|
rats, sprague-dawley |
3 |
|
rd207 |
3 |
|
receptor-binding domain |
3 |
|
receptors, ccr5 - genetics |
3 |
|
receptors, virus - genetics - immunology |
3 |
|
receptors, virus - metabolism |
3 |
|
recombinant proteins - antagonists & inhibitors - metabolism |
3 |
|
recombinant proteins - metabolism |
3 |
|
reference values |
3 |
|
regression modeling |
3 |
|
resistance |
3 |
|
respiratory burst |
3 |
|
respiratory insufficiency - diagnosis - etiology |
3 |
|
respiratory tract infections - chemically induced - complications |
3 |
|
respiratory tract infections - epidemiology - microbiology |
3 |
|
respiratory viral infection |
3 |
|
respirovirus infections - etiology |
3 |
|
rflp analysis |
3 |
|
rifampin - pharmacology |
3 |
|
rm-act-1 |
3 |
|
rna - biosynthesis - genetics |
3 |
|
rna, ribosomal, 16s - classification |
3 |
|
rna, ribosomal, 18s - analysis - genetics |
3 |
|
rna, small interfering - biosynthesis - genetics - pharmacology |
3 |
|
rna, small interfering - genetics - pharmacology |
3 |
|
rna, viral - chemistry - genetics |
3 |
|
rodent diseases - diagnosis - epidemiology - virology |
3 |
|
rpob transformation |
3 |
|
rv2820c |
3 |
|
saccharomyces cerevisiae - classification - genetics |
3 |
|
saesxa |
3 |
|
saesxb |
3 |
|
safety |
3 |
|
salmonella - classification - isolation & purification |
3 |
|
salmonella enterica - classification - isolation & purification - physiology |
3 |
|
salmonella enterica - immunology |
3 |
|
salmonella infections - diagnosis - drug therapy - microbiology |
3 |
|
salmonella infections - epidemiology - microbiology |
3 |
|
salmonella typhi |
3 |
|
salmonella typhi - classification - isolation & purification |
3 |
|
salmonella typhi - immunology |
3 |
|
salmonella typhimurium - genetics - immunology |
3 |
|
salpingitis - microbiology |
3 |
|
sarcoptes scabiei |
3 |
|
sars virus - drug effects - genetics - physiology |
3 |
|
sars virus - drug effects - physiology |
3 |
|
sars virus - enzymology |
3 |
|
scabies - diagnosis - drug therapy |
3 |
|
scarlet fever - complications - diagnosis |
3 |
|
sentinel surveillance |
3 |
|
septic arthritis |
3 |
|
sequence analysis, dna - methods |
3 |
|
serologic tests |
3 |
|
severe acute respiratory syndrome - diagnosis - epidemiology - prevention & control |
3 |
|
severe acute respiratory syndrome - epidemiology - immunology - prevention & control |
3 |
|
severe acute respiratory syndrome - immunology - prevention & control |
3 |
|
severe acute respiratory syndrome - immunology - prevention & control - virology |
3 |
|
severe acute respiratory syndrome - prevention & control - transmission |
3 |
|
severe acute respiratory syndrome - prevention and control |
3 |
|
sex distribution |
3 |
|
shigella flexneri - drug effects - enzymology - isolation & purification |
3 |
|
siblings |
3 |
|
skin diseases, bacterial - diagnosis - microbiology - pathology |
3 |
|
small molecule inhibitor |
3 |
|
snake |
3 |
|
spectrometry, fluorescence - methods |
3 |
|
spitting behavior |
3 |
|
spores, fungal - drug effects - genetics - radiation effects - ultrastructure |
3 |
|
sputum |
3 |
|
sputum - cytology - drug effects - immunology - microbiology |
3 |
|
sputum - microbiology |
3 |
|
sputum pathogens |
3 |
|
st414 |
3 |
|
staff education |
3 |
|
staphylococcaceae - drug effects - genetics |
3 |
|
staphylococcaceae - genetics |
3 |
|
staphylococcal infections - diagnosis |
3 |
|
staphylococcal skin infections - epidemiology - microbiology |
3 |
|
streptococcal infections - diagnosis - drug therapy - epidemiology |
3 |
|
streptococcus agalactiae - classification - isolation & purification |
3 |
|
streptococcus pyogenes - classification - genetics - isolation & purification |
3 |
|
strongyloidiasis |
3 |
|
subdomain 1 |
3 |
|
surgical site abscess |
3 |
|
surveillance |
3 |
|
survival analysis |
3 |
|
swine origin influenza virus a/h1n1 |
3 |
|
synovitis - etiology |
3 |
|
t3ss |
3 |
|
talaromycosis |
3 |
|
telomere - genetics |
3 |
|
teta gene |
3 |
|
tetr gene |
3 |
|
tetracycline resistance - genetics |
3 |
|
therapeutic vaccine |
3 |
|
thermus thermophilus - genetics |
3 |
|
toxic scarlet fever |
3 |
|
transformation, bacterial - genetics |
3 |
|
transient immunodeficiency |
3 |
|
transplantation, autologous |
3 |
|
transplantation, liver |
3 |
|
treatment failure |
3 |
|
trimethoprim-sulfamethoxazole combination - pharmacology |
3 |
|
tuberculosis - diagnosis |
3 |
|
tuberculosis - immunology |
3 |
|
tuberculosis - microbiology |
3 |
|
tuberculosis, splenic - complications - diagnosis - drug therapy |
3 |
|
tumor virus infections - complications - urine - virology |
3 |
|
tumor virus infections - drug therapy - etiology |
3 |
|
tumor virus infections - drug therapy - virology |
3 |
|
tumor virus infections - immunology - urine - virology |
3 |
|
typhoid fever - drug therapy - immunology |
3 |
|
typhoid fever - etiology |
3 |
|
typing |
3 |
|
ultraviolet rays |
3 |
|
urban population |
3 |
|
vaccination - statistics & numerical data |
3 |
|
vaccines |
3 |
|
vaccines, attenuated - immunology |
3 |
|
vaccines, inactivated - administration & dosage |
3 |
|
vancomycin - pharmacology |
3 |
|
vancomycin-resistant enterococcus faecium |
3 |
|
vancomycin-resistant staphylococcus aureus |
3 |
|
vasculitis, leukocytoclastic, cutaneous - drug therapy - microbiology |
3 |
|
vedolizumab |
3 |
|
vibrio cholerae - classification |
3 |
|
vibrio cholerae - genetics - metabolism |
3 |
|
victoria lineage |
3 |
|
viral envelope proteins - administration & dosage - immunology |
3 |
|
viral envelope proteins - administration and dosage - genetics - immunology |
3 |
|
viral infections |
3 |
|
viral matrix proteins - genetics - immunology |
3 |
|
viral proteins - antagonists & inhibitors - metabolism |
3 |
|
viral proteins - genetics - immunology - metabolism |
3 |
|
viral vaccines - administration & dosage - immunology |
3 |
|
viral vaccines - administration & dosage - immunology - pharmacology |
3 |
|
viral vaccines - administration and dosage - genetics - immunology |
3 |
|
virulence attributes |
3 |
|
virus latency |
3 |
|
vocal cords - pathology |
3 |
|
voice disorders - diagnosis - etiology - virology |
3 |
|
waldenstrom macroglobulinemia - complications - microbiology |
3 |
|
water |
3 |
|
water buffalo |
3 |
|
water chlorination |
3 |
|
water supply |
3 |
|
water supply - standards |
3 |
|
weil disease - complications - therapy |
3 |
|
west africa |
3 |
|
zoonoses - transmission - virology |
3 |
|
16s |
2 |
|
16s ribosomal rna sequencing |
2 |
|
16s rrna |
2 |
|
16s rrna sequencing |
2 |
|
accidents, traffic |
2 |
|
acetamides - pharmacology |
2 |
|
acquired immunodeficiency syndrome - complications - drug therapy |
2 |
|
acremonium - isolation & purification |
2 |
|
actinomycetales infections - complications |
2 |
|
actinomycetales infections - drug therapy - radiography |
2 |
|
acute myeloid leukemia |
2 |
|
adamantane |
2 |
|
adaptationautophagy |
2 |
|
adefovir dipivoxil |
2 |
|
adefovir dipivoxil plus emtricitabine |
2 |
|
adenine - administration & dosage - adverse effects - analogs & derivatives - therapeutic use |
2 |
|
aids-related opportunistic infections - diagnosis - drug therapy - microbiology |
2 |
|
aids-related opportunistic infections - diagnosis - microbiology |
2 |
|
aids-related opportunistic infections - diagnosis - microbiology - physiopathology |
2 |
|
air microbiology |
2 |
|
alanine transaminase - blood |
2 |
|
alcohol consumption |
2 |
|
alcoholism - complications |
2 |
|
allograft skin |
2 |
|
amikacin - therapeutic use |
2 |
|
amino acids - genetics - immunology |
2 |
|
amphotericin b |
2 |
|
anemia, hemolytic, autoimmune - diagnosis - drug therapy |
2 |
|
anemia, refractory, with excess of blasts - microbiology |
2 |
|
animal-diseases-transmission |
2 |
|
ant venoms - toxicity |
2 |
|
anti-bacterial agents - adverse effects - therapeutic use |
2 |
|
anti-hiv agents - therapeutic use |
2 |
|
anti-inflammatory agents - therapeutic use |
2 |
|
antibodies, monoclonal - genetics - immunology |
2 |
|
antibodies, viral - therapeutic use |
2 |
|
antigenic sites |
2 |
|
antigenic variation |
2 |
|
antigens, fungal - analysis |
2 |
|
antigens, fungal - analysis - genetics - immunology |
2 |
|
antigens, fungal - cerebrospinal fluid |
2 |
|
antigens, viral - biosynthesis |
2 |
|
antigens, viral - blood - drug effects |
2 |
|
antimicrobial resistance epidemiology |
2 |
|
antiviral agents - administration & dosage - therapeutic use |
2 |
|
ants |
2 |
|
arcobacter - classification - genetics - isolation & purification |
2 |
|
aspergillosis - complications - diagnosis |
2 |
|
aspergillosis - diagnosis - epidemiology - prevention & control |
2 |
|
aspergillus - immunology - isolation and purification |
2 |
|
aspergillus flavus - isolation and purification |
2 |
|
bacteremia - complications |
2 |
|
bacteremia - diagnosis - drug therapy - etiology |
2 |
|
bacteremia - etiology |
2 |
|
bacterial infections - epidemiology |
2 |
|
bacterial toxins - genetics |
2 |
|
bacteriuria - microbiology |
2 |
|
base sequence - genetics |
2 |
|
beta-lactamases - chemistry - genetics - metabolism |
2 |
|
biological sciences |
2 |
|
biotin - metabolism |
2 |
|
blood and marrow transplant |
2 |
|
blood donors - statistics & numerical data |
2 |
|
blood platelets - drug effects |
2 |
|
body modification |
2 |
|
body piercing |
2 |
|
body temperature - drug effects |
2 |
|
bone marrow |
2 |
|
bone marrow hypoplasia |
2 |
|
breast |
2 |
|
breast implants |
2 |
|
british columbia - epidemiology |
2 |
|
burns |
2 |
|
buttocks |
2 |
|
c-reactive protein - analysis |
2 |
|
cambodia |
2 |
|
candidiasis - diagnosis - microbiology |
2 |
|
capsid proteins |
2 |
|
cardiac surgical procedures - adverse effects |
2 |
|
catheter-associated infection |
2 |
|
catheterization, peripheral - adverse effects |
2 |
|
cell membrane - metabolism |
2 |
|
cell transformation, viral |
2 |
|
cerebrospinal fluid shunts - methods |
2 |
|
chaphamaparvovirus |
2 |
|
chemoprophylaxis |
2 |
|
chickenpox |
2 |
|
chickens |
2 |
|
chromogenic agar |
2 |
|
chronic alcoholism |
2 |
|
chronic lymphatic leukemia |
2 |
|
cirrhosis |
2 |
|
clinical practice |
2 |
|
clostridium - isolation & purification |
2 |
|
clostridium clostridiiforme |
2 |
|
clostridium infections - epidemiology - etiology |
2 |
|
clostridium infections - etiology |
2 |
|
cmv dnaemia |
2 |
|
cobas amplicor™ |
2 |
|
codon |
2 |
|
colchicine |
2 |
|
colchicine - poisoning |
2 |
|
colonoscopy |
2 |
|
colony-forming units assay |
2 |
|
combined modality therapy |
2 |
|
communicable disease control - methods |
2 |
|
communicable diseases, emerging - diagnosis - epidemiology - therapy |
2 |
|
community-acquired infections - epidemiology - microbiology - transmission |
2 |
|
compliance |
2 |
|
coronavirus 229e, human - metabolism |
2 |
|
coronavirus infections - metabolism |
2 |
|
corynebacteria |
2 |
|
crf01-ae |
2 |
|
crocodile |
2 |
|
cross infection - diagnosis - microbiology |
2 |
|
cross infection - microbiology - transmission |
2 |
|
cross infection - virology |
2 |
|
cross species transmission |
2 |
|
cryptococcaemia |
2 |
|
cryptococcal meningitis |
2 |
|
cryptococcus neoformans - classification - genetics - immunology - isolation & purification |
2 |
|
crystallography, x-ray |
2 |
|
cyclosporine |
2 |
|
cytomegalic endothelial cell |
2 |
|
cytomegalovirus - classification - genetics - isolation and purification |
2 |
|
cytomegalovirus - drug effects - genetics - immunology - isolation & purification |
2 |
|
cytomegalovirus - genetics |
2 |
|
cytomegalovirus - immunology - isolation & purification |
2 |
|
cytomegalovirus infections - diagnosis - drug therapy - immunology - virology |
2 |
|
cytomegalovirus infections - epidemiology |
2 |
|
cytoplasmic granules - metabolism |
2 |
|
debridement - methods |
2 |
|
dentistry |
2 |
|
deoxycytidine - administration & dosage - adverse effects - analogs & derivatives |
2 |
|
diabetes complications |
2 |
|
diabetes mellitus - immunology |
2 |
|
diamond-blackfan syndrome |
2 |
|
diarrhea - immunology - microbiology |
2 |
|
diarrhea - pathology - virology |
2 |
|
diarrhoea |
2 |
|
disease re-emergence |
2 |
|
disease transmission, infectious - prevention & control |
2 |
|
disease-free survival |
2 |
|
dna probes |
2 |
|
dna, viral |
2 |
|
doxycycline - therapeutic use |
2 |
|
drug sensitivity |
2 |
|
drug-drug interactions |
2 |
|
economic development |
2 |
|
empowered patients |
2 |
|
empyema |
2 |
|
enfuvirtide |
2 |
|
enteral nutrition |
2 |
|
enteritis - pathology - virology |
2 |
|
enterobacter cloacae - classification |
2 |
|
enterobacteriaceae |
2 |
|
enterobacteriaceae - classification - genetics - isolation & purification |
2 |
|
enterobacteriaceae - classification - genetics - isolation & purification - metabolism |
2 |
|
enterobacteriaceae infections - diagnosis - immunology |
2 |
|
enterobacteriaceae infections - microbiology |
2 |
|
enterococcus - drug effects |
2 |
|
entry inhibitor |
2 |
|
environment |
2 |
|
environmental monitoring - methods |
2 |
|
enzyme-linked immunoassay |
2 |
|
epidemiological monitoring |
2 |
|
epitope mapping |
2 |
|
epitopes - chemistry - genetics - immunology |
2 |
|
escherichia coli - enzymology - growth & development |
2 |
|
evan's syndrome |
2 |
|
evolution analysis |
2 |
|
exotoxins - genetics |
2 |
|
extremities - surgery |
2 |
|
family characteristics |
2 |
|
family health |
2 |
|
fanconi anemia - therapy |
2 |
|
fascia - pathology - surgery |
2 |
|
fasciitis - complications - microbiology |
2 |
|
fasciitis - complications - microbiology - pathology |
2 |
|
fasciitis, necrotizing - diagnosis - etiology - therapy |
2 |
|
fasciitis, necrotizing - pathology - surgery |
2 |
|
fatality |
2 |
|
fibrosis |
2 |
|
fluorescent antibody technique |
2 |
|
fluoroquinolones - adverse effects - therapeutic use |
2 |
|
fontan procedure - adverse effects |
2 |
|
fungal infection |
2 |
|
gammaproteobacteria - classification - genetics - isolation & purification - physiology |
2 |
|
ganciclovir - administration & dosage - therapeutic use |
2 |
|
gastrointestinal diseases |
2 |
|
genes, pol |
2 |
|
gout suppressants - poisoning |
2 |
|
gp41 |
2 |
|
graft vs host disease - etiology |
2 |
|
gram-negative bacterial infections - diagnosis - drug therapy - etiology |
2 |
|
granuloma, plasma cell - etiology - metabolism - pathology |
2 |
|
h7n7 |
2 |
|
ha |
2 |
|
haart |
2 |
|
hand hygiene ambassador |
2 |
|
healthcare worker |
2 |
|
hemagglutinin glycoproteins, influenza virus - chemistry - genetics - immunology |
2 |
|
hemagglutinins |
2 |
|
hemoglobins - drug effects |
2 |
|
hemoptysis - etiology |
2 |
|
hemosiderosis |
2 |
|
hepatitis b e antigens - blood |
2 |
|
hepatitis b, chronic - complications - virology |
2 |
|
hepatitis b, chronic - drug therapy - virology |
2 |
|
herpesvirus 4, human - immunology - isolation & purification - physiology |
2 |
|
high-touch |
2 |
|
hiv |
2 |
|
hiv envelope protein gp41 - genetics - pharmacology |
2 |
|
hiv infections - complications |
2 |
|
hiv infections - complications - epidemiology - transmission - virology |
2 |
|
hiv infections - epidemiology |
2 |
|
hiv infections - virology |
2 |
|
hiv protease - genetics |
2 |
|
hiv-1 - classification - genetics |
2 |
|
hiv-1 - classification - genetics - isolation & purification |
2 |
|
hiv-1 - drug effects - genetics - isolation and purification |
2 |
|
homosexuality, male |
2 |
|
hotel |
2 |
|
human bocavirus - genetics - metabolism |
2 |
|
human-to-human transmission |
2 |
|
ileal diseases - etiology - metabolism - pathology |
2 |
|
ileum |
2 |
|
immunization programs |
2 |
|
immunocompromised host - immunology |
2 |
|
immunocompromised patient |
2 |
|
immunodominant positions |
2 |
|
immunoglobulins - immunology - isolation & purification - therapeutic use |
2 |
|
immunologic factors - therapeutic use |
2 |
|
immunomodulators |
2 |
|
immunosuppression |
2 |
|
infant, premature |
2 |
|
infant, premature, diseases - diagnosis - microbiology |
2 |
|
infection - epidemiology |
2 |
|
infection-transmission |
2 |
|
infectious disease transmission, vertical |
2 |
|
inflammatory pseudotumour |
2 |
|
inflammatory response |
2 |
|
influenza a virus - classification - immunology |
2 |
|
influenza a virus - pathogenicity |
2 |
|
influenza a virus, avian |
2 |
|
influenza a virus, h1n1 subtype - metabolism - physiology |
2 |
|
influenza a virus, h5n1 subtype |
2 |
|
influenza a virus, h5n1 subtype - drug effects - genetics - immunology - metabolism |
2 |
|
influenza a virus, h5n1 subtype - genetics - immunology |
2 |
|
influenza a virus, h5n1 subtype - pathogenicity |
2 |
|
influenza a virus, h7n7 subtype - pathogenicity |
2 |
|
influenza a virus, h9n2 subtype |
2 |
|
influenza a virus, human |
2 |
|
influenza in birds - drug therapy - epidemiology - prevention & control - transmission |
2 |
|
influenza in birds - transmission - virology |
2 |
|
influenza vaccines - administration & dosage - adverse effects |
2 |
|
influenza, human - diagnosis - immunology - virology |
2 |
|
influenza, human - drug therapy - epidemiology - prevention & control |
2 |
|
influenza, human - epidemiology - pathology - prevention & control - therapy |
2 |
|
influenza, human - immunology - prevention & control |
2 |
|
influenza, human - prevention & control/virology |
2 |
|
insect bites and stings - complications |
2 |
|
interferon type i - therapeutic use |
2 |
|
interferon-alpha |
2 |
|
iris |
2 |
|
itraconazole |
2 |
|
klebsiella - enzymology - growth & development |
2 |
|
klebsiella infections |
2 |
|
klebsiella pneumoniae |
2 |
|
klebsiella species |
2 |
|
laundry |
2 |
|
leg injuries - complications - therapy |
2 |
|
legionella pneumophila - isolation & purification |
2 |
|
legionnaires' disease - complications - diagnosis |
2 |
|
letter |
2 |
|
leukemia, myelogenous, chronic, bcr-abl positive - therapy |
2 |
|
leukemia, promyelocytic, acute - therapy |
2 |
|
leukocidins - genetics |
2 |
|
leukocytes - drug effects |
2 |
|
linens |
2 |
|
lipoproteins |
2 |
|
listeria monocytogenes |
2 |
|
listeriosis - etiology |
2 |
|
liver cirrhosis |
2 |
|
liver cirrhosis - complications |
2 |
|
liver cirrhosis - etiology |
2 |
|
lung abscess |
2 |
|
lung abscess - drug therapy - radiography |
2 |
|
lung diseases - epidemiology |
2 |
|
lung diseases, fungal - epidemiology |
2 |
|
lupus |
2 |
|
lupus erythematosus, systemic - complications - drug therapy |
2 |
|
lupus erythematosus, systemic - epidemiology - microbiology |
2 |
|
lupus erythematosus, systemic - virology |
2 |
|
lymphatic diseases - etiology - metabolism - pathology |
2 |
|
lymphocytes - immunology |
2 |
|
lymphohistiocytosis, hemophagocytic - blood - etiology |
2 |
|
macrophage infectivity potentiator |
2 |
|
malassezia - isolation & purification |
2 |
|
mass screening |
2 |
|
matrix-assisted laser desorption ionization–time of flight |
2 |
|
mediastinal emphysema - etiology - radiography |
2 |
|
membrane glycoproteins - analysis - chemistry - metabolism |
2 |
|
membrane glycoproteins - analysis - genetics - immunology |
2 |
|
meningitis, bacterial - epidemiology - microbiology - transmission |
2 |
|
meningitis, cryptococcal - cerebrospinal fluid - diagnosis |
2 |
|
meningitis, cryptococcal - complications - diagnosis - drug therapy |
2 |
|
mesotherapy |
2 |
|
methicillin |
2 |
|
methicillin-resistant staphylococcus aureus - genetics - isolation & purification |
2 |
|
mp1p |
2 |
|
muscle, skeletal |
2 |
|
mutagenesis, insertional |
2 |
|
mutual-touch |
2 |
|
mycobacterium chelonae - isolation & purification |
2 |
|
mycobacterium infections, atypical - etiology - radiography |
2 |
|
mycobacterium tuberculosis - genetics - isolation & purification |
2 |
|
mycoplasma - isolation & purification |
2 |
|
mycoplasma hominis |
2 |
|
mycoplasma infections - diagnosis - drug therapy - microbiology |
2 |
|
mycoses - blood - diagnosis - epidemiology |
2 |
|
mycoses - complications - drug therapy |
2 |
|
mycoses - diagnosis - drug therapy - microbiology |
2 |
|
mycoses - diagnosis - etiology |
2 |
|
mycoses - diagnosis - microbiology - physiopathology |
2 |
|
mycoses - epidemiology |
2 |
|
mycoses - microbiology - transmission |
2 |
|
nasal vaccine |
2 |
|
necrosis |
2 |
|
nephro- lalcinosis |
2 |
|
nephrocalcinosis - complications |
2 |
|
nested pcr |
2 |
|
neuraminidase inhibitors |
2 |
|
nmr resonance assignment |
2 |
|
nocardia |
2 |
|
nocardia infections - epidemiology |
2 |
|
nocardia infections - transmission |
2 |
|
nocardia otitidis coviarum |
2 |
|
normalization of serum alanine aminotransaminase |
2 |
|
northwestern united states - epidemiology |
2 |
|
nucleic acid amplification techniques |
2 |
|
nucleocapsid proteins - analysis - immunology |
2 |
|
nuclisens easyq™ |
2 |
|
nutrition disorders - immunology |
2 |
|
ofloxacin - pharmacology |
2 |
|
oligonucleotide probes |
2 |
|
oncogene proteins - genetics |
2 |
|
oncogene proteins, viral |
2 |
|
opportunistic infection |
2 |
|
opportunistic infections - diagnosis/epidemiology |
2 |
|
opportunistic infections - drug therapy - radiography |
2 |
|
opportunistic infections - epidemiology |
2 |
|
orthomyxoviridae infections - transmission - virology |
2 |
|
oxazolidinones - pharmacology |
2 |
|
parasites |
2 |
|
parenteral nutrition, total - adverse effects |
2 |
|
parvoviridae |
2 |
|
patient admission |
2 |
|
patient hand hygiene |
2 |
|
patient isolation |
2 |
|
pb2 |
2 |
|
pcr test |
2 |
|
penicillium - chemistry - genetics - immunology |
2 |
|
penicillium - classification |
2 |
|
penicillium - drug effects - growth & development - isolation & purification |
2 |
|
penicillium - growth & development - isolation & purification |
2 |
|
peramivir |
2 |
|
perianal abscess |
2 |
|
persons who inject drugs |
2 |
|
phosphonic acids - administration & dosage - adverse effects - therapeutic use |
2 |
|
phosphoproteins - blood |
2 |
|
pneumocystis jiroveci - isolation & purification |
2 |
|
pneumocystis jirovecii - *isolation & purification |
2 |
|
pneumomediastinum |
2 |
|
pneumonia - epidemiology |
2 |
|
pneumonia, bacterial - complications - diagnosis - microbiology |
2 |
|
pneumonia, pneumocystis - diagnosis - drug therapy |
2 |
|
pneumonia, pneumocystis - diagnosis/epidemiology |
2 |
|
pneumothorax |
2 |
|
pol gene products, human immunodeficiency virus - genetics |
2 |
|
polymerase chain reaction -methods |
2 |
|
population surveillance |
2 |
|
porcine reproductive and respiratory syndrome - diagnosis - epidemiology - immunology |
2 |
|
porcine respiratory and reproductive syndrome virus - immunology - isolation & purification |
2 |
|
pp65 assay |
2 |
|
ppiase domain |
2 |
|
practice guidelines |
2 |
|
pregnancy complications, infectious - epidemiology - virology |
2 |
|
propionibacterium - isolation & purification - pathogenicity |
2 |
|
propionibacterium avidum |
2 |
|
prostheses and implants - microbiology |
2 |
|
protease inhibitors |
2 |
|
protein processing, post-translational |
2 |
|
protein subunit vaccine |
2 |
|
protein transport |
2 |
|
protein-losing enteropathies - complications - etiology |
2 |
|
pseudomonas infections - complications - metabolism - pathology |
2 |
|
pseudomonas veronii |
2 |
|
pulmonary infections |
2 |
|
pyelonephritis - diagnosis - drug therapy - microbiology |
2 |
|
quarantine |
2 |
|
rabbits |
2 |
|
real-time polymerase chain reaction - methods |
2 |
|
recombinant proteins |
2 |
|
recurrence |
2 |
|
respiration - drug effects |
2 |
|
respiratory tract infections - drug therapy - virology |
2 |
|
rhesus monkey |
2 |
|
rhinosinusitis |
2 |
|
rhodococcus equi |
2 |
|
rhodococcus equi - isolation & purification |
2 |
|
ribonucleoproteins - genetics - metabolism |
2 |
|
ribosomal |
2 |
|
rifampicin |
2 |
|
rifampin - therapeutic use |
2 |
|
rna |
2 |
|
rna scaffold |
2 |
|
rna, bacterial |
2 |
|
sars virus - growth & development |
2 |
|
sars virus - isolation & purification - physiology |
2 |
|
screening methods |
2 |
|
seawater - microbiology |
2 |
|
self-adjuvanted |
2 |
|
sepsis - microbiology |
2 |
|
septicemia |
2 |
|
serum hbv dna suppression |
2 |
|
severe acute respiratory syndrome - complications |
2 |
|
severe acute respiratory syndrome - complications - drug therapy - radiography |
2 |
|
severe acute respiratory syndrome - complications - pathology |
2 |
|
severe acute respiratory syndrome - diagnosis - epidemiology - therapy |
2 |
|
severe acute respiratory syndrome - diagnosis - epidemiology - transmission - virology |
2 |
|
severe acute respiratory syndrome - diagnosis - therapy |
2 |
|
severe acute respiratory syndrome - immunology - physiopathology |
2 |
|
severe acute respiratory syndrome - metabolism |
2 |
|
shigella flexneri - drug effects - enzymology - genetics - isolation & purification |
2 |
|
shock, surgical - complications |
2 |
|
skates (fish) |
2 |
|
soft tissue infections - epidemiology - microbiology - transmission |
2 |
|
staphylococcal infections - epidemiology - microbiology - prevention & control |
2 |
|
staphylococcal infections - epidemiology - microbiology - transmission |
2 |
|
staphylococcal skin infections - epidemiology - microbiology - transmission |
2 |
|
staphylococcus aureus - drug effects |
2 |
|
staphylococcus aureus - drug effects - genetics |
2 |
|
staphylococcus aureus - drug effects - isolation & purification |
2 |
|
statistics, nonparametric |
2 |
|
steroids - therapeutic use |
2 |
|
strongyloides stercoralis |
2 |
|
strongyloidiasis - immunology |
2 |
|
subcutaneous cellulitis |
2 |
|
subtype diversity |
2 |
|
surgical trauma |
2 |
|
surgical wound infection - microbiology |
2 |
|
syndrome |
2 |
|
systemic lupus erythematosus |
2 |
|
taiwan - epidemiology |
2 |
|
tattooing |
2 |
|
terminology |
2 |
|
therapeutic use |
2 |
|
thermostable dna polymerase |
2 |
|
thrombocytopenia - diagnosis - drug therapy |
2 |
|
tilapia |
2 |
|
transplant |
2 |
|
transportation |
2 |
|
trichostrongylosis - etiology - physiopathology |
2 |
|
trichostrongylus |
2 |
|
tropheryma whipplei |
2 |
|
tuberculosis - blood - complications |
2 |
|
tuberculosis - drug therapy - epidemiology - etiology |
2 |
|
tuberculosis, pulmonary - diagnosis |
2 |
|
tuberculosis, pulmonary - diagnosis - drug therapy |
2 |
|
tuberculosis, pulmonary - drug therapy - epidemiology |
2 |
|
tuberculosis, pulmonary - epidemiology |
2 |
|
upper lrinary tract infection |
2 |
|
uracil-n-glycosylase |
2 |
|
vaccines, attenuated |
2 |
|
vaccines, inactivated |
2 |
|
vaccinia virus - genetics |
2 |
|
ventilation system |
2 |
|
vibrio |
2 |
|
vibrio infections |
2 |
|
vibrio infections - complications - diagnosis - therapy |
2 |
|
vibrionaceae - classification - isolation & purification |
2 |
|
viral entry |
2 |
|
viral envelope proteins - analysis - chemistry - metabolism |
2 |
|
viral envelope proteins - biosynthesis - genetics |
2 |
|
viral envelope proteins - chemistry - genetics - immunology |
2 |
|
viral load monitoring |
2 |
|
viral matrix proteins - blood |
2 |
|
viral nonstructural proteins - metabolism |
2 |
|
viral vaccines - administration & dosage |
2 |
|
virulence factor |
2 |
|
weight gain |
2 |
|
whipple’s disease |
2 |
|
whole-body irradiation |
2 |
|
wound healing - drug effects |
2 |
|
wound infection - microbiology |
2 |
|
wound infection - pathology |
2 |
|
yeasts - genetics - metabolism |
2 |
|
zoonoses-transmission |
2 |
|
zygomycosis |
2 |
|
acute kidney injury - complications |
1 |
|
acyclovir - administration & dosage - therapeutic use |
1 |
|
aids-related opportunistic infections - diagnosis - immunology - microbiology |
1 |
|
air conditioning |
1 |
|
ambulatory care |
1 |
|
aminoglycosides |
1 |
|
amoxicillin - therapeutic use |
1 |
|
animals, wild |
1 |
|
anti-bacterial agents - administration & dosage - adverse effects - pharmacokinetics |
1 |
|
antibodies, fungal - biosynthesis - immunology |
1 |
|
antibodies, monoclonal |
1 |
|
antibodies, monoclonal - biosynthesis - immunology |
1 |
|
antibodies, viral |
1 |
|
anticoagulants - therapeutic use |
1 |
|
antigens, bacterial - isolation & purification |
1 |
|
antigens, fungal - immunology |
1 |
|
antigens, surface - genetics - immunology - metabolism |
1 |
|
antigens, surface - isolation & purification |
1 |
|
antigens, viral |
1 |
|
antiviral agents - chemical synthesis - pharmacology |
1 |
|
antivirals |
1 |
|
artificial ventilation |
1 |
|
asthma - complications |
1 |
|
asymptomatic individuals |
1 |
|
avian influenza a(h7n9) virus |
1 |
|
bacteria-growth-and-development |
1 |
|
bacterial infections - drug therapy |
1 |
|
bacteriophages - genetics |
1 |
|
beta-lactam resistance |
1 |
|
beta-lactamases - antagonists & inhibitors |
1 |
|
beta-lactamases - antagonists & inhibitors - metabolism |
1 |
|
beta-lactams |
1 |
|
biological markers |
1 |
|
biopsy, needle |
1 |
|
biosafety |
1 |
|
bioterrorism - history |
1 |
|
brain stem - pathology |
1 |
|
bronchial diseases - microbiology |
1 |
|
brucellosis |
1 |
|
campylobacter |
1 |
|
campylobacter fetus |
1 |
|
campylobacter infections - complications - congenital - transmission |
1 |
|
campylobacter infections - diagnosis |
1 |
|
campylobacter pylori |
1 |
|
candida tropicalis |
1 |
|
candidiasis - epidemiology - microbiology |
1 |
|
capsule |
1 |
|
carbohydrate sequence |
1 |
|
central nervous system infections - complications - diagnosis - virology |
1 |
|
cerebellum - pathology |
1 |
|
clpi |
1 |
|
communicable diseases - drug therapy - enzymology |
1 |
|
communicable diseases, emerging - epidemiology |
1 |
|
communication |
1 |
|
confidence intervals |
1 |
|
coronavirinae |
1 |
|
coronavirus - enzymology |
1 |
|
coronaviruses |
1 |
|
cox proportional hazdard model |
1 |
|
cross infection - diagnosis - epidemiology - microbiology - prevention & control |
1 |
|
cross infection - prevention & control |
1 |
|
cross infection - prevention & control - transmission |
1 |
|
cryptococcus |
1 |
|
ctd |
1 |
|
cysteine - pharmacology |
1 |
|
cysteine endopeptidases - chemistry - metabolism |
1 |
|
cysteine proteinase inhibitors - chemical synthesis - pharmacology |
1 |
|
data collection |
1 |
|
database management systems |
1 |
|
dengue - diagnosis - virology |
1 |
|
dengue virus - isolation & purification |
1 |
|
diabetes mellitus |
1 |
|
disease outbreaks - history |
1 |
|
disposable-equipment-standards |
1 |
|
disseminated infection |
1 |
|
drug administration schedule |
1 |
|
drug carriers |
1 |
|
drug design |
1 |
|
drug resistant |
1 |
|
duodenal-ulcer-microbiology |
1 |
|
education, nursing - methods |
1 |
|
electrophoresis, polyacrylamide gel |
1 |
|
encephalitis - drug therapy - microbiology |
1 |
|
enzyme inhibitors - pharmacology - therapeutic use |
1 |
|
enzyme inhibitors - therapeutic use |
1 |
|
equipment-contamination |
1 |
|
escherichia coli - drug effects - immunology |
1 |
|
escherichia coli infections - complications - microbiology |
1 |
|
evaluation studies as topic |
1 |
|
extensively drug-resistant bacteria |
1 |
|
extracorporeal circulation |
1 |
|
extracorporeal membrane oxygenation - methods |
1 |
|
false positive reactions |
1 |
|
fluconazole |
1 |
|
fluoroquinolone |
1 |
|
fungal proteins - analysis - blood - genetics |
1 |
|
gastritis - diagnosis - microbiology |
1 |
|
gastroscopy |
1 |
|
genome, viral - genetics |
1 |
|
glasgow coma scale |
1 |
|
glucocorticoids - administration & dosage |
1 |
|
hand washing |
1 |
|
health care personnel |
1 |
|
health care system |
1 |
|
health personnel |
1 |
|
helicobacter-infections-complications |
1 |
|
helicobacter-pylori |
1 |
|
hemagglutinins, viral - genetics |
1 |
|
herpes zoster - drug therapy |
1 |
|
history, 19th century |
1 |
|
history, 21st century |
1 |
|
hospital bed capacity, 500 and over |
1 |
|
hospital management |
1 |
|
hospital units |
1 |
|
hospitals, public |
1 |
|
hospitals, teaching |
1 |
|
human novel influenza a (h1n1) virus |
1 |
|
hybridomas - immunology |
1 |
|
hygiene - education |
1 |
|
immunoassay |
1 |
|
immunocompetent host |
1 |
|
immunoglobulin m - blood |
1 |
|
immunoglobulins, intravenous - adverse effects |
1 |
|
immunostaining |
1 |
|
infection - diagnosis - drug therapy |
1 |
|
infectious disease transmission, patient-to-professional |
1 |
|
influenza a virus - pathogenicity - physiology |
1 |
|
influenza a virus, h1n1 subtype |
1 |
|
influenza a virus, h1n1 subtype - chemistry - genetics |
1 |
|
influenza a virus, h1n1 subtype - isolation & purification |
1 |
|
influenza a virus, h5n1 subtype - growth & development - immunology |
1 |
|
influenza in birds - epidemiology - transmission |
1 |
|
influenza vaccines - administration & dosage - adverse effects - immunology |
1 |
|
influenza, human |
1 |
|
influenza, human - complications - pathology |
1 |
|
influenza, human - complications - therapy |
1 |
|
influenza, human - diagnosis - therapy - transmission - virology |
1 |
|
inservice training - methods |
1 |
|
interferon-gamma - metabolism |
1 |
|
interleukins - metabolism |
1 |
|
interprofessional relations |
1 |
|
ipd meta-analysis |
1 |
|
k-nearest neighbour algorithm |
1 |
|
kidney calculi - complications |
1 |
|
kidney failure, chronic - complications - therapy |
1 |
|
laboratories |
1 |
|
laboratory management |
1 |
|
laboratory-based immunoassays for sars-cov-2 detection |
1 |
|
latex fixation tests |
1 |
|
leadership |
1 |
|
leukoencephalitis, acute hemorrhagic - etiology - pathology |
1 |
|
liposomes |
1 |
|
logistic regression |
1 |
|
lung diseases - microbiology |
1 |
|
lung diseases, obstructive - complications |
1 |
|
lymphopenia - complications |
1 |
|
mastectomy, modified radical |
1 |
|
medicine |
1 |
|
membrane glycoproteins - analysis - blood - genetics |
1 |
|
membrane glycoproteins - immunology - physiology |
1 |
|
methicillin-resistant staphylococcus aureus (mrsa) |
1 |
|
methylprednisolone - administration & dosage |
1 |
|
methylprednisolone - therapeutic use |
1 |
|
molecular biology - methods |
1 |
|
molecular diagnostic techniques |
1 |
|
molecular structure |
1 |
|
moraxella (branhamella) catarrhalis - drug effects |
1 |
|
moraxella (branhamella) catarrhalis - isolation & purification - pathogenicity |
1 |
|
mucormycosis |
1 |
|
mucormycosis - complications - drug therapy - microbiology |
1 |
|
multi-fluorescent real-time rt-pcr |
1 |
|
multivariate survival analysis |
1 |
|
mycobacterium - genetics - isolation & purification |
1 |
|
mycobacterium tuberculosis - classification - genetics - isolation & purification |
1 |
|
mycoses - complications |
1 |
|
nebulizers-and-vaporizers-standards |
1 |
|
neisseria - isolation & purification |
1 |
|
neonatal infection |
1 |
|
new drugs |
1 |
|
nonstructural proteins |
1 |
|
nucleocapsid - blood |
1 |
|
nucleocapsid proteins - blood |
1 |
|
oligonucleotide array sequence analysis |
1 |
|
oligopeptides - chemical synthesis - pharmacology |
1 |
|
opportunistic infections - etiology |
1 |
|
orthopedics |
1 |
|
oxazoles - chemical synthesis - pharmacology |
1 |
|
oxygenators, membrane |
1 |
|
pandemic influenza |
1 |
|
pandemic vaccine |
1 |
|
penicillin resistance |
1 |
|
penicillium - immunology |
1 |
|
penicillium - immunology - isolation & purification |
1 |
|
peptide fragments - immunology |
1 |
|
peritoneal dialysis, continuous ambulatory |
1 |
|
peritonitis - epidemiology - microbiology |
1 |
|
peritonitis - etiology |
1 |
|
phase i/ii |
1 |
|
placenta consumption |
1 |
|
plague - history |
1 |
|
pneumococcal infections - drug therapy |
1 |
|
pneumonia - drug therapy - microbiology |
1 |
|
point-of-care immunoassays for sars-cov-2 detection |
1 |
|
pre-pandemic vaccine |
1 |
|
pregnancy complications, infectious |
1 |
|
pregnancy complications, infectious - virology |
1 |
|
primary gastritis |
1 |
|
probability |
1 |
|
problem solving |
1 |
|
prognostication |
1 |
|
protective devices |
1 |
|
protein structure, quaternary |
1 |
|
pulmonary embolism - drug therapy - radiography - virology |
1 |
|
pyrrolidinones - chemical synthesis - pharmacology |
1 |
|
randomized controlled trials as topic |
1 |
|
rapid detection |
1 |
|
rapid urease test |
1 |
|
receptors, virus - chemistry |
1 |
|
recombinant proteins - immunology - isolation & purification - metabolism |
1 |
|
reliability theory |
1 |
|
respiratory distress syndrome, adult - epidemiology - mortality - therapy |
1 |
|
respiratory tract infections - microbiology |
1 |
|
rna-binding proteins - chemistry - genetics - metabolism |
1 |
|
sars virus - chemistry - genetics - metabolism |
1 |
|
sars virus - genetics - immunology - metabolism |
1 |
|
sars-cov-2 antigen rapid detection tests |
1 |
|
scarlet fever |
1 |
|
selection (genetics) |
1 |
|
sepsis - complications - epidemiology - microbiology |
1 |
|
sepsis - complications - microbiology |
1 |
|
sequence homology |
1 |
|
serum - virology |
1 |
|
severe acute respiratory syndrome - blood - virology |
1 |
|
severe acute respiratory syndrome - complications - virology |
1 |
|
severe acute respiratory syndrome - drug therapy - physiopathology |
1 |
|
severe acute respiratory syndrome - epidemiology |
1 |
|
severe acute respiratory syndrome - epidemiology - immunology - |
1 |
|
severe acute respiratory syndrome - transmission - virology |
1 |
|
severe acute respiratory syndrome coronavirus 2 (sars-cov-2) |
1 |
|
severe acute respiratory syndrome-associated coronavirus |
1 |
|
signal processing, computer-assisted |
1 |
|
singapore |
1 |
|
social distancing |
1 |
|
specialization |
1 |
|
staff roster |
1 |
|
staphylococcal infections - diagnosis - epidemiology - microbiology - prevention & control |
1 |
|
static electricity |
1 |
|
steptococcus pyogenes |
1 |
|
sterilization-standards |
1 |
|
streptococcal infections - complications - epidemiology - microbiology |
1 |
|
streptococcus |
1 |
|
structure |
1 |
|
superantigen |
1 |
|
surgical-wound-infection-diagnosis |
1 |
|
thalamus - pathology |
1 |
|
tomography, x-ray computed - methods |
1 |
|
transmissible gastroenteritis virus - enzymology |
1 |
|
trichosporon |
1 |
|
tuberculosis,-pulmonary-diagnosis |
1 |
|
tumor necrosis factor-alpha - metabolism |
1 |
|
urease - diagnostic use |
1 |
|
urinary catheterization - standards |
1 |
|
urinary tract infections - complications - microbiology |
1 |
|
vaccination - adverse effects - methods |
1 |
|
viral envelope proteins - immunology - physiology |
1 |
|
viral nonstructural proteins - blood |
1 |
|
viral pneumonia |
1 |
|
viral proteins - antagonists & inhibitors |
1 |
|
weil disease - radiography |
1 |
|
wet-warming |
1 |
|
wound healing - physiology |
1 |